Continucare Corporation
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
|
|
|
|
þ |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended: June 30, 2005
OR
|
|
|
|
o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 001-12115
CONTINUCARE CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
Florida
(State or other jurisdiction of
incorporation or organization)
|
|
59-2716023
(I.R.S. Employer
Identification No.) |
7200 Corporate Center Drive,
Suite 600
Miami, Florida 33126
(Address of principal executive offices)
(305) 500-2000
(Registrants telephone number, including area code:)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
|
|
Name of each exchange on which registered |
COMMON STOCK
|
|
AMERICAN STOCK EXCHANGE |
$.0001 PAR VALUE |
|
|
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendments to this Form 10-K. þ
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No
þ
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule
12b-2 of the Exchange Act). Yes o No þ
Aggregate market value of the voting and non-voting common equity held by non-affiliates of
the registrant at September 1, 2005 (computed by reference to the last reported sale price of the
registrants Common Stock on the American Stock Exchange on such date): $46,372,130.
Number of shares outstanding of each of the registrants classes of Common Stock at September 1,
2005: 49,880,602 shares of Common Stock, $.0001 par value per share.
CONTINUCARE CORPORATION
ANNUAL REPORT ON FORM 10-K
FOR THE YEAR ENDED JUNE 30, 2005
TABLE OF CONTENTS
2
GENERAL
Unless otherwise indicated or the context otherwise requires, all references in this Form 10-K
to we, us, our, Continucare or the Company refer to Continucare Corporation and its
consolidated subsidiaries. All references to a Fiscal year refer to our fiscal year which ends
June 30. As used herein, Fiscal 2006 refers to the fiscal year ending June 30, 2006, Fiscal 2005
refers to fiscal year ended June 30, 2005, Fiscal 2004 refers to fiscal year ended June 30, 2004,
and Fiscal 2003 refers to fiscal year ended June 30, 2003.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
All statements included in this Annual Report other than statements of historical fact, are
forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and we intend that
such forward-looking statements be subject to the safe harbors created thereby. These
forward-looking statements are based on our current expectations, estimates and projections about
our industry, managements beliefs, and certain assumptions made by us, all of which are subject to
change. Forward-looking statements can often be identified by words such as anticipates,
expects, intends, plans, predicts, believes, seeks, estimates, may, will,
should, would, could, potential, continue, similar expressions, and variations or
negatives of these words. These forward-looking statements are not guarantees of future results
and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore,
our actual results could differ materially and adversely from those expressed in any
forward-looking statement as a result of various factors. Forward-looking statements may include
statements about:
|
|
|
Our ability to make capital expenditures and respond to capital needs; |
|
|
|
|
Our ability to enhance the services we provide to our patients; |
|
|
|
|
Our ability to strengthen our medical management capabilities; |
|
|
|
|
Our ability to improve our physician network; |
|
|
|
|
Our ability to enter into or renew our managed care agreements and negotiate terms
which are favorable to us and affiliated physicians; |
|
|
|
|
Our ability to respond to future changes in Medicare reimbursement levels and
reimbursement rates from other third parties; |
|
|
|
|
Our compliance with applicable laws and regulations; |
|
|
|
|
Our ability to establish relationships and expand into new geographic markets; |
|
|
|
|
Our ability to expand our network through additional medical centers or other facilities; |
|
|
|
|
The potential impact on our claims loss ratio as a result of the Medicare Risk
Adjustments (MRA) and the Medicare Prescription Drug, Improvement and Modernization
Act of 2003 (the Medicare Modernization Act); and |
|
|
|
|
Our ability to utilize our net operating losses for Federal income tax purposes. |
Forward-looking statements involve risks and uncertainties that cannot be predicted or
quantified and, consequently, actual results may differ materially from those expressed or implied
by such forward-looking statements. Forward-looking statements, therefore, should be considered in
light of all of the information included or incorporated by reference in this Annual Report,
including the section entitled Risk Factors. Such risks and uncertainties include, but are not
limited to the following:
|
|
|
Our ability to respond to capital needs; |
|
|
|
|
Our ability to achieve expected levels of patient volumes and control the costs of providing services; |
|
|
|
|
Pricing pressures exerted on us by managed care organizations; |
|
|
|
|
The level of payments we receive from governmental programs and other third party payors; |
|
|
|
|
Our ability to successfully recruit and retain qualified medical professionals; |
|
|
|
|
Future legislative changes in governmental regulations, including possible changes in
Medicare programs that may impact reimbursements to health care providers and insurers; |
|
|
|
|
Our ability to comply with applicable laws and regulations; |
|
|
|
|
The impact of the Medicare Modernization Act and MRA on payments we receive for our managed care operations; |
|
|
|
|
Technological and pharmaceutical improvements that increase the cost of providing, or
reduce the demand for, health care; |
|
|
|
|
Changes in our revenue mix and claims loss ratio; |
|
|
|
|
Changes in the range of medical services we provide or for
which our HMO affiliates offer coverage; |
|
|
|
|
Our ability to enter into and renew managed care provider agreements on acceptable terms; |
|
|
|
|
Loss of significant contracts, including the PGP Agreement; |
|
|
|
|
The ability of our compliance program to detect and prevent regulatory compliance problems; |
3
|
|
|
Delays in receiving payments; |
|
|
|
|
Increases in the cost of insurance coverage, including our stop-loss coverage, or the loss of insurance coverage; |
|
|
|
|
The collectibility of our uninsured accounts and deductible and co-pay amounts; |
|
|
|
|
Federal and state investigations; |
|
|
|
|
Lawsuits for medical malpractice and the outcome of any such litigation; |
|
|
|
|
Changes in estimates and judgments associated with our critical accounting policies; |
|
|
|
|
Our dependence on our information processing systems and the management information
systems of our HMO affiliates; |
|
|
|
|
Impairment charges that could be required in future periods; |
|
|
|
|
General economic conditions; and |
|
|
|
|
Uncertainties generally associated with the health care business. |
We caution our investors not to place undue emphasis on these forward-looking statements,
which speak only as of the date of this Annual Report and we undertake no obligation to update or
revise these statements as a result of new information, future events or otherwise.
RISK FACTORS
Our operations are dependent on two health maintenance organizations.
We derive substantially all of our net medical services revenues under our managed care
agreements with two health maintenance organizations (HMOs), Humana Medical Plans, Inc.
(Humana) and Vista Healthplan of South Florida, Inc. and its affiliated companies (Vista). In
Fiscal 2005, we generated approximately 78% of our revenues from contracts with Humana and 22% of
our revenues from contracts with Vista. Most of our business with Humana is governed by one
agreement (the Humana POP Agreement). The loss of the Humana POP Agreement or our managed care
agreement with Vista, or significant reductions in payments to us under these contracts, could have
a material adverse effect on our business, financial condition and results of operations.
Under our most important contracts we are responsible for the cost of medical services to our
patients in return for a fixed fee.
Our most important contracts with Humana and Vista are full risk agreements under which we
receive for our services fixed monthly payments per patient at a rate established by the contract,
also called a capitated fee. In return, we assume full financial responsibility for the provision
of all necessary medical care to our patients, even services we do not provide directly.
Accordingly, we will be unable to adjust the revenues we receive under those contracts, and if
medical claims expense exceeds our estimates our profits may decline. Relatively small changes in
the ratio of our health care expenses to capitated revenues we receive can create significant
changes in our financial results.
If we are unable to manage medical benefits expense effectively, our profitability will likely be
reduced.
We cannot be profitable if our costs of providing the required medical services exceed the
revenues that we derive from those services. However, our most important contracts with Humana and
Vista require us to assume full financial responsibility for the provision of all necessary medical
care in return for a capitated fee per patient at a rate established by the contract. Accordingly,
as the costs of providing medical services to our patients under those contracts increases, the
profits we receive with respect to those patients decreases. If we cannot continue to improve our
controls and procedures for estimating and managing our costs, our business, results of operations,
financial condition and ability to satisfy our obligations could be adversely affected.
A failure to estimate incurred but not reported medical benefits expense accurately will affect our
profitability.
Our medical benefits expense includes estimates of medical claims incurred but not reported,
or IBNR. We estimate our medical cost liabilities using actuarial methods based on historical data
adjusted for payment patterns, cost trends, utilization of health care services and other relevant
factors. Actual conditions, however, could differ from those assumed in the estimation process.
Due to the inherent uncertainties associated with the factors used in these assumptions, materially
different amounts could be reported in our financial statements for a particular period under
different possible conditions or using different, but still reasonable, assumptions. Adjustments,
if necessary, are made to medical benefits expense when the criteria used to determine IBNR change
and when actual claim costs are ultimately determined. Although we believe our past estimates of
IBNR have been adequate, they may prove to have been inadequate in the future and our future
estimates may not be adequate, any of which would adversely affect our results of operations.
Further, our inability to estimate IBNR accurately may also affect our ability to take timely
corrective actions, further exacerbating the extent of any adverse effect on our results.
4
Many factors that increase health care costs are largely beyond our ability to control.
Increased utilization or unit cost, competition, government regulations and many other factors
may, and often do, cause actual health care costs to increase and these cost increases can
adversely impact our profitability. These factors may include, among other things:
|
|
|
increased use of medical facilities and services, including prescription drugs and doctors office visits; |
|
|
|
|
increased cost of such services; |
|
|
|
|
new benefits to patients added by the HMOs to their covered services, whether as
a result of the Medicare Modernization Act or otherwise; |
|
|
|
|
changes or reductions of our utilization management functions such as
preauthorization of services, concurrent review or requirements for physician
referrals; |
|
|
|
|
catastrophes (including hurricanes), epidemics or terrorist attacks; |
|
|
|
|
the introduction of new or costly treatments, including new technologies; |
|
|
|
|
new government mandated benefits or other regulatory changes; and |
|
|
|
|
increases in the cost of stop loss or other insurance. |
Many of these factors are beyond our ability to control or predict.
Health care reform initiatives, particularly changes to the Medicare system, could adversely effect
our operations.
Substantially all of our net medical services revenues from continuing operations are based
upon Medicare funded programs. The federal government from time to time explores ways to reduce
medical care costs through Medicare reform and through health care reform generally. Any changes
that would limit, reduce or delay receipt of Medicare funding or any developments that would
disqualify us from receiving Medicare funding could have a material adverse effect on our business,
results of operations, prospects, financial results, financial condition or cash flows. Due to the
diverse range of proposals put forth and the uncertainty of any proposals adoption, we cannot
predict what impact any Medicare reform proposal ultimately adopted may have on our business,
financial position or results of operations.
Medicare premiums have generally risen more slowly than the cost of providing health care services.
Our revenues are largely determined by the premiums that the Centers for Medicare and Medicaid
Services (CMS) pay to our affiliated HMOs under their Medicare Advantage (formerly known as
Medicare+Choice) contracts. Although CMS has generally increased the premiums paid to the HMOs for
Medicare Advantage patients each year, the rate of increase has generally been less than the rate
at which the cost of providing health care services, including prescription drugs, has increased on
a national average. As a result, we are under increasing pressure to contain our costs, and the
margin we realize on providing health care services has generally decreased over time. There can
be no assurance that CMS will maintain its premiums at the current level or continue to increase
its premiums each year. Additionally there can be no assurances that we will receive the total
benefit of any premium increase the HMOs may receive.
Our revenues will be affected by the Medicare Risk Adjustment program.
The majority of patients to whom we provide care are Medicare-eligible and participate in the
Medicare Advantage program. CMS is now implementing its Medicare Risk Adjustment project during
which it is transitioning its premium calculation methodology to a new system that takes into
account the health status of Medicare Advantage participants in determining premiums paid for each
participant rather than only considering demographic factors, as was historically the case.
Beginning January 1, 2004, the new risk adjustment system required that ambulatory data be
incorporated into the premium calculation, starting from a blend consisting of a 30% risk
adjustment payment and the remaining 70% based on demographic factors. For 2005, the blend of
demographic risk adjustment payments and demographic factors were given equal weight. Thereafter
the blend percentages will be adjusted as follows:
|
|
|
|
|
|
|
|
|
|
|
Risk |
|
Demographic |
Year |
|
Percentage |
|
Percentage |
2006 |
|
|
75 |
% |
|
|
25 |
% |
2007 |
|
|
100 |
% |
|
|
0 |
% |
We believe the new risk adjustment methodology has generally increased our revenues per
patient to date but cannot assure what future impact this new risk adjustment methodology will
continue to have on our business, results of operations, or financial
condition. It is also possible that the new risk adjustment methodology may result in
fluctuations in our medical services revenues
5
from year to year.
Intangible assets represent a substantial portion of our total assets.
Our balance sheet includes intangible assets, including goodwill and other separately
identifiable intangible assets, which represented approximately 45% of our total assets at June 30,
2005. We are required to review our intangible assets for impairment on an annual basis or more
frequently if certain indicators of permanent impairment arise. Indicators of a permanent
impairment include, among other things:
|
|
|
a significant adverse change in legal factors or the business climate; |
|
|
|
|
the loss of a key HMO contract; |
|
|
|
|
an adverse action by a regulator; |
|
|
|
|
unanticipated competition; |
|
|
|
|
loss of key personnel; or |
|
|
|
|
allocation of goodwill to a portion of business that is to be sold. |
Because we operate in a single segment of business, we perform our impairment test on an
enterprise level. In performing the impairment test, we compare our fair value, as determined by
the current market value of our common stock, to the current value of the total net assets,
including goodwill and intangible assets. We completed our annual impairment test on May 1, 2005,
and determined that no impairment existed. Accordingly, no impairment charges were required at June
30, 2005. Should we determine that an indicator of impairment has occurred, such as those noted
above, we would be required to perform an additional impairment test. Depending on the market
value of our common stock at the time that an impairment test is required, there is a risk that a
portion of our intangible assets would be considered impaired and must be written-off during that
period. Such a write-off could have a material adverse effect on our results of operations.
We are subject to government regulation.
Our business is regulated by the federal government and the State of Florida. The laws and
regulations governing our operations are generally intended to benefit and protect health plan
members and providers rather than our shareholders. The government agencies administering these
laws and regulations have broad latitude to enforce them. These laws and regulations, along with
the terms of our contracts, regulate how we do business, what services we offer, and how we
interact with our patients, other providers and the public. We are subject to various governmental
reviews, audits and investigations to verify our compliance with our contracts and applicable laws
and regulations. Any adverse review, audit or investigation could result in:
|
|
|
forfeiture of amounts we have been paid; |
|
|
|
|
imposition of civil or criminal penalties, fines or other sanctions on us; |
|
|
|
|
loss of our right to participate in government-sponsored programs, including Medicare; |
|
|
|
|
damage to our reputation in various markets; |
|
|
|
|
increased difficulty in hiring or retaining qualified medical personnel or marketing our products and services; and |
|
|
|
|
loss of one or more of our licenses to provide health care services. |
Any of these events could reduce our revenues and profitability and otherwise adversely affect
our operating results.
The health care industry is subject to continued scrutiny.
The health care industry, generally, and HMOs specifically, have been the subject of increased
government and public scrutiny in recent years, which has focused on the appropriateness of the
care provided, referral and marketing practices and other matters. Increased media and public
attention has focused on the outpatient services industry in particular as a result of allegations
of fraudulent practices related to the nature and duration of patient treatments, illegal
remuneration and certain marketing, admission and billing practices by certain health care
providers. The alleged practices have been the subject of federal and state investigations, as
well as other legal proceedings. There can be no assurance that we or our HMO affiliates will not
be subject to federal and state review or investigation from time to time, and any such
investigation could adversely impact our business or results of operations, even if we are not
ultimately found to have violated the law.
We compete with many health care providers for patients and HMO affiliations.
The health care industry is highly competitive. We compete for patients with many other
health care providers, including
local physicians and practice groups as well as local, regional and national networks of
physicians and health care companies. We
6
believe that competition for patients is generally based
upon the reputation of the physician treating the patient, the physicians expertise, and the
physicians demeanor and manner of engagement with the patient, and the HMOs that the physician is
affiliated with. We also compete with other local, regional and national networks of physicians
and health care companies for the services of physicians and for HMO affiliations. Some of our
competitors have greater resources than we do, and we may not be able to continue to compete
effectively in this industry. Further, additional competitors may enter our markets, and this
increased competition may have an adverse effect on our revenues.
The agreement relating to most of our IPA relationships may be modified or terminated.
As of June 30, 2005, our independent physician affiliates (IPAs) provided services to
approximately 725 patients on a full risk basis and to approximately 7,600 patients on a limited or
non-risk basis. Most of our IPA relationships, including most of our non-risk IPA relationships,
are governed under a single Physician Group Participation Agreement that we entered into with
Humana in April 2003 (the Humana PGP Agreement). The initial term of the Humana PGP Agreement
ended in March 2005, but the Humana PGP Agreement continues by its terms until the agreement is
cancelled by either party subject to prior notice. We are engaged in discussions with Humana
regarding a possible modification and extension of the Humana PGP Agreement, but it is not possible
to predict at this time whether we will ultimately agree to modify or agree to extend the Humana
PGP Agreement. In addition, any modification or extension that we agree to may be on different
terms and provide for different obligations on the part of the respective parties than the terms
and obligations currently provided for in the Humana PGP Agreement.
We may not be able to successfully recruit or retain existing relationships with qualified
physicians and medical professionals.
We depend on our physicians and other medical professionals to provide medical services to our
managed care patients and independent physicians contracting with us to participate in provider
networks we develop or manage. We compete with general acute care hospitals and other health care
providers for the services of medical professionals. Demand for physicians and other medical
professionals is high and such professionals often receive competing offers. If we are unable to
successfully recruit and retain medical professionals our ability to successfully implement our
business strategy could suffer. No assurance can be given that we will be able to continue to
recruit and retain a sufficient number of qualified physicians and other medical professionals.
Our business exposes us to the risk of medical malpractice lawsuits.
Our business entails an inherent risk of claims against physicians for professional services
rendered to patients, and we periodically become involved as a defendant in medical malpractice
lawsuits. Medical malpractice claims are subject to the attendant risk of substantial damage
awards. Although we maintain insurance against these claims, if liability results from any of our
pending or any future medical malpractice claims, there can be no assurance that our medical
malpractice insurance coverage will be adequate to cover liability arising out of these
proceedings. There can be no assurance that pending or future litigation will not have a material
adverse affect on us or that liability resulting from litigation will not exceed our insurance
coverage.
Our insurance coverage may not be adequate, and rising insurance premiums could negatively affect
our profitability.
We rely on insurance to protect us from many business risks, including, stop loss insurance.
In most cases, as is the trend in the health care industry, as insurance policies expire, we may
be required to procure policies with narrower coverage, more exclusions and higher premiums. In
some cases, coverage may not be available at any price. There can be no assurance that the
insurance that we maintain and intend to maintain will be adequate, or that the cost of insurance
and limitations in coverage will not adversely affect our business, financial position or results
of operations.
Deficit spending and economic downturns could negatively impact our results of operations.
Adverse developments in the economy often result in decreases in the federal budget and
associated changes in the federal governments spending priorities. We are presently in a period
of deficit spending by the federal government, and those deficits are presently expected to
continue for at least the next several years. Continued deficit spending by the federal government
could lead to increased pressure to reduce governmentally funded programs such as Medicare. If
governmental funding of the Medicare program was reduced without a counterbalancing adjustment in
the benefits offered to patients, our results of operations could be negatively impacted.
We presently operate only in Florida.
All of our medical services revenues are presently derived from our operations in Florida.
Adverse economic, regulatory, or
other developments in Florida (including hurricanes) could have a material adverse effect on
our financial condition or results of
7
operations. In the event that we expand our operations into
new geographic markets, we will need to establish new relationships with physicians and other
health care providers. In addition, we will be required to comply with laws and regulations of
states that differ from the ones in which we currently operate, and may face competitors with
greater knowledge of such local markets. There can be no assurance that we will be able to
establish relationships, realize management efficiencies or otherwise establish a presence in new
geographic markets.
A significant portion of our voting power is concentrated in one shareholder.
One of our directors, Dr. Phillip Frost, and entities affiliated with him, beneficially owned
approximately 45% of our outstanding common stock as of September 1, 2005. Based on Dr. Frosts
significant beneficial ownership of our common stock, he has a substantial ability to influence
most corporate actions requiring shareholder approval, including the election of directors, and
will be able to effectively control any shareholder votes or actions with respect to such matter.
This influence by Dr. Frost may make us less attractive as a target for a takeover proposal. It
may also make it more difficult to discourage a merger proposal that Dr. Frost favors or to wage a
proxy contest for the removal of incumbent directors. As a result, this may deprive the holders of
our common stock of an opportunity they might otherwise have to sell their shares at a premium over
the prevailing market price in connection with a merger or acquisition of us or with or by another
company.
We are dependent on our executive officers and other key employees.
Our operations are highly dependent on the efforts of our Chief Executive Officer and our
other key employees. Our executive officers and key employees do not have employment agreements
with us, but are instead employed on an at will basis. While we believe that we could find
replacements, the loss of any of their leadership, knowledge and experience could negatively impact
our operations. Replacing any of our executive officers or key employees might be difficult or
take an extended period of time because a limited number of individuals in the managed care
industry have the breadth and depth of skills and experience necessary to operate a business such
as ours. Our success is also dependent on our ability to hire and retain qualified management,
technical and medical personnel. We may be unsuccessful in recruiting and retaining such
personnel, which could negatively impact our operations.
We depend on the management information systems of our affiliated HMOs.
Our operations are dependent on the management information systems of the HMOs with which we
contract. Our affiliated HMOs provide us with certain financial and other information, including
reports and calculations of costs of services provided and payments to be received by us. Both the
software and hardware our HMO affiliates use to provide us with that information have been subject
to rapid technological change. Because we rely on this technology but do not own it, we have
limited ability to ensure that it is properly maintained, serviced and updated. In addition,
information systems such as these may be vulnerable to failure, acts of sabotage such as hacking,
and obsolescence. If either of our principal HMO affiliates were to temporarily or permanently
lose the use of the information systems that provide us with the information on which we depend or
the underlying patient and physician data, our business and results of operations could be
materially and adversely affected. Because our HMO affiliates generate certain of the information
on which we depend, we have less control over the manner in which that information is generated
than we would if we generated the information internally.
We depend on our information processing systems.
Our information processing systems allow us to monitor the medical services we provide to
patients. They also enable us to provide our HMO affiliates with information they use to calculate
the payments due to us. These systems are vital to our growth. Although we license most of our
information processing systems from third-party vendors we believe to be reliable, we developed
certain elements of our information processing systems on our own. Our current systems may not
perform as expected or provide efficient operational solutions if:
|
|
|
we fail to adequately identify or are unsuccessful in implementing all of our information and processing needs; |
|
|
|
|
our processing or information systems fail; or |
|
|
|
|
we fail to upgrade systems when required. |
During the fourth quarter of Fiscal 2005, we became aware of a latent error in an automated
software system used to submit particular patient data to one of our HMO affiliates. Because the
data formed an element of the HMOs calculation of payments due to us, the error resulted in us
over-stating revenue associated with that one HMO. We believe that we have corrected the software
error and that we are now able to submit correct patient data. However, a disruption in or failure
of our operational support systems could result in loss of revenue from billings, or an incorrect
calculation of the amounts due to us from our HMO affiliates, any of which
could have a material adverse effect on our business, results of operations and financial
condition.
8
Volatility of our stock price could adversely affect you.
The market price of our common stock could fluctuate significantly as a result of many
factors, including factors that are beyond our ability to control or foresee and which, in some
cases, may be wholly unrelated to us or our business. These factors include:
|
|
|
state and federal budget decreases; |
|
|
|
|
adverse publicity regarding HMOs and other managed care organizations; |
|
|
|
|
government action regarding eligibility; |
|
|
|
|
changes in government payment levels; |
|
|
|
|
changes in state mandatory programs; |
|
|
|
|
changes in expectations of our future financial performance or changes in financial
estimates, if any, of public market analysts; |
|
|
|
|
announcements relating to our business or the business of our competitors; |
|
|
|
|
conditions generally affecting the managed care industry or our provider networks; |
|
|
|
|
the success of our operating strategy; |
|
|
|
|
the operating and stock price performance of other comparable companies; |
|
|
|
|
the termination of any of our contracts; |
|
|
|
|
regulatory or legislative changes; |
|
|
|
|
acts of war or terrorism or an increase in hostilities in the world; and |
|
|
|
|
general economic conditions, including inflation and unemployment rates. |
PART I
ITEM 1. BUSINESS
General
We are a mixed model provider of primary care physician services. Through our network of 15
medical centers we provide primary health care services on an outpatient basis. We also provide
practice management services to 27 IPAs. All of our medical centers and IPAs are located in
Miami-Dade, Broward and Hillsborough Counties, Florida. As of June 30, 2005, we provided services
to or for approximately 28,000 patients through our medical centers and IPAs. A majority of these
patients participate in the Medicare Advantage (formerly known as Medicare+Choice) program.
We were incorporated in Florida in 1996 as the successor to a Florida corporation formed
earlier in 1996. During Fiscal 2000 and 2001 we restructured much of our indebtedness, including
the convertible subordinated notes we then had outstanding. During Fiscal 2004, the notes were
converted into shares of our common stock. In an effort to streamline operations and stem
operating losses, effective January 1, 2003, we terminated the Medicare and Medicaid lines of
business for all of our IPA relationships associated with one HMO. Additionally, in February 2004,
we completed the disposition of our home health operations. As a result of these transactions, the
operations of the terminated IPAs and our home health operations are shown as discontinued
operations.
Our principal place of business is 7200 Corporate Center Drive, Suite 600, Miami, Florida
33126. Our telephone number is 305-500-2000.
Industry Overview
The United States health care market is large and growing. According to CMS, total outlays on
health care in the United States were $1.7 trillion in 2003 and were projected to reach $3.6
trillion in 2014, representing an annual rate of increase of approximately 7.1%. The rate of the
overall increase of health care outlays in the United States has been greater than the growth of
the economy as a whole (measured by gross domestic product, or GDP). For example, in 2003 the rate
of growth of total United States medical outlays was three percentage points higher than the growth
of GDP. The high growth rate of health care outlays is expected to continue. In 2003, health care
outlays represented 15.3% of GDP. CMS projects that this amount will increase to 18.7% of GDP by
2014. In addition, United States health care outlays have increased at a faster rate than the
consumer price index. In early 2005, CMS projected that United States medical outlays grew by
approximately 7.5% in 2004, as compared to actual increases of 7.7% in 2003, 9.3% in 2002 and 8.5%
in 2001.
The Medicare sector of the United States health care market is also large and growing.
Medicare provided health care
9
benefits to approximately 42 million elderly and disabled Americans
in 2004, or approximately 14% of the population of the United States. With the coming retirement
of the Baby Boom generation, a significant increase in the number of Medicare beneficiaries is
forecast, with the number of Medicare beneficiaries expected to rise to over 75 million, or greater
than 20% of the projected population of the United States, by 2030. Medicare outlays have also
grown faster than both the GDP and the consumer price index, which growth is forecast to continue.
For example, annual Medicare outlays exceeded $220 billion in 2003 and are expected to grow to over
$400 billion by 2012.
Medicare was established in 1965 and traditionally provided fee-for-service (indemnity)
coverage for its members. Under fee-for-service coverage, Medicare assumes responsibility for
paying all or a portion of the members covered medical fees, subject, in some cases, to a
deductible or coinsurance payment. The Medicare Advantage program represents private health plans
participation in Medicare. Through a contract with CMS, private insurers, such as HMOs, may
contract with CMS to provide health insurance coverage in exchange for a fixed monthly payment per
member per month for Medicare-eligible individuals. Individuals who elect to participate in
Medicare Advantage typically receive additional benefits not covered by Medicares traditional
fee-for-service coverage program and are relieved of the obligation to pay some or all deductible
or coinsurance amounts due.
Participation in private Medicare managed care programs (then called Medicare+Choice)
increased during the 1990s reaching a peak of 6.2 million participants in 1998, or approximately
16% of the Medicare-eligible population. As of November 2003, the number of participants had
decreased to 4.6 million, or approximately 11% of the Medicare-eligible population. The number of
participating private health plans also decreased during this period going from 346 plans in 1998
to 155 in November 2003. This decline in participation has been attributed to unpredictable and
insufficient payments resulting from the alteration of payments to private plans associated with
the Balanced Budget Act of 1997.
The Medicare Modernization Act, adopted in December 2003, was intended, in part, to modernize
and revitalize private plans under Medicare. At a cost currently estimated to be over $700 billion
for the next ten years, the Medicare Modernization Act provides for a Medicare prescription drug
offering beginning in 2006, established new tax-advantaged Health Savings Account regulations and
made significant changes to the Medicare Advantage program. The changes to the Medicare Advantage
program were a response to the decreased managed care participation in Medicare and the resulting
lack of choice for Medicare beneficiaries. The Medicare Modernization Act made favorable changes
to the premium rate calculation methodology and generally provides for program rates that we
believe will better reflect the increased cost of medical services provided to Medicare
beneficiaries.
As a result of the growing increases in health care outlays in the United States, insurers,
employers, state and federal governments and other health insurance payors have sought to reduce or
control the sustained increases in health care costs. One response to these cost increases has
been a shift away from the traditional fee-for-service method of paying for health care to managed
health care models, such as HMOs.
HMOs offer a comprehensive health care benefits package in exchange for a fixed prepaid
monthly fee or premium per enrollee that does not vary through the contract period regardless of
the quantity of medical services required or used. HMOs enroll members by entering into contracts
with employer groups or directly with individuals to provide a broad range of health care services
for a prepaid charge, with minimal deductibles or co-payments required of the members. HMOs
contract directly with medical clinics, independent physician associations, hospitals and other
health care providers to administer medical care to HMO enrollees. The affiliated physician
organization contracts with the HMOs provide for payment to the affiliated physician organizations.
Often the payment to the affiliated physician organization is in the form of a fixed monthly fee
per enrollee, which is called a capitation payment. Once negotiated, the total payment is based on
the number of enrollees covered, regardless of the actual need for and utilization of covered
services.
Physicians, including sole practitioners and small physician groups, find themselves at a
competitive disadvantage in the current managed care environment. Physicians are generally not
equipped by training or experience to handle all of the functions of a modern medical practice,
such as negotiation of contracts with specialists and HMOs, claims administration, financial
services, provider relations, member services, medical management including utilization management
and quality assurance, data collection and management information systems. Additionally, a
proliferation of state and federal regulations has increased the paper-work burden and hampered the
application of the traditional controls used by managed care organizations. Physicians
increasingly are responding to these pressures within the managed care industry by affiliating with
organizations such as us to assist them in managing their practices.
Our Market and Business Strategy
The population of Florida was approximately 17.4 million in 2004, and approximately 30% of
those residents are located in Miami-Dade, Broward and Hillsborough Counties. As of June 30, 2005, approximately 520,000
residents of Florida were enrolled in
10
Medicare Advantage plans out of a Medicare-eligible
population of approximately 3.0 million. The three HMOs with which we are affiliated account for
approximately 48% of Medicare Advantage patients in the markets we serve.
Our strategy is to:
|
|
|
increase patient volume at our existing medical centers through enhanced marketing efforts; |
|
|
|
|
consider adding new HMO affiliations; |
|
|
|
|
selectively expand our network to include additional medical centers or other medical
facilities and to penetrate new geographic markets; and |
|
|
|
|
further develop our IPA management activities. |
Increasing Patient Volume
Our core business is comprised of our established network of medical centers from which we
provide primary care services on an outpatient basis. In addition, we provide services to a
network of IPAs. As of June 30, 2005, we provided services under agreements with HMOs relating to
both our medical centers and the IPAs to approximately 13,600 patients on a full risk basis and
approximately 14,100 patients on a limited or non-risk basis. For our full risk patients we assume
full financial responsibility for the provision of substantially all necessary medical care to
those patients in return for a fixed fee per member per month. For our limited or non-risk
patients, we are responsible only for the services we actually provide to those patients, and not
the cost of specialists, hospitalization or other services that we do not provide. In addition, we
provide primary care services on a fee-for-service basis. We seek to increase the number of
patients using our medical centers through the general marketing efforts of our affiliated HMOs and
on our own through targeted marketing efforts with a particular focus on Medicare eligible
patients.
Consider Adding New HMO Affiliations
We are currently affiliated with three HMOs Humana and Vista, with whom we have
long-standing relationships, and Wellcare, Inc. (Wellcare) with whom we became affiliated in
September 2004. We work closely with our affiliated HMOs and strive to attain a high level of HMO
satisfaction with our services. We believe that increasingly margin conscious HMOs value our
operational strengths and expertise at providing quality health care, retaining patients and
effectively managing medical utilization. As a result, we believe that we are well positioned to
establish additional HMO affiliations to enable us to serve a larger number of the patients in our
markets. There can be no assurances that we will obtain additional HMO affiliations and, depending
upon a number of factors, including the level of support we are receiving from our current HMO
affiliates, we may elect not to pursue additional affiliates.
Selectively Expanding Our Network
We may seek to add additional medical centers or other medical facilities to our network
either through acquisition or start up, although no assurance can be given of our ability to
establish or acquire any additional locations. To date, we have focused on Miami-Dade, Broward and
Hillsborough Counties, Florida. We expect we will identify and select acquisition candidates based
in large part on the following broad criteria:
|
|
|
a history of profitable operations or a predictable synergy such as opportunities for
economies of scale through a consolidation of management functions; |
|
|
|
|
a competitive environment with respect to a high concentration of hospitals and physicians; and |
|
|
|
|
a geographic proximity to our current operations. |
Developing Our IPA Management Activities
We also seek to add additional IPAs, although no assurance can be given of our ability to
establish any of those IPA relationships. We believe that HMOs are increasingly reluctant to
contract directly with sole practitioners and small physician groups who wish to accept HMO
patients on a risk basis, preferring instead to contract with management service organizations such
as us. We enhance the operations of our IPA physician practices by providing assistance with
medical utilization management, pharmacy management and specialist network development.
Additionally, we provide financial reports for our IPA practices to further assist with their
operations. We believe that we can leverage our skill at providing practice management services to
IPA practices to a larger
group of IPA practices and will seek to selectively add new IPA practices to enhance our IPA
management activities. We intend to
11
continue affiliating with physicians who are sole
practitioners or who operate in small groups to staff and expand our network.
Our Medical Centers
At our medical centers physicians who are our employees or independent contractors act as
primary care physicians practicing in the area of general, family and internal medicine. A typical
medical center is operated in an office space that ranges from 5,000 to 8,000 square feet. A
medical center is typically staffed with approximately two to three physicians, and is open five
days a week. The physicians we employ or with whom we contract are generally retained under
written agreements that provide for a rolling one-year term, subject to earlier termination in some
circumstances. Under our standard physician agreements we are responsible for providing our
physicians with malpractice insurance coverage.
Our IPAs
We provide practice management assistance to IPAs. Our services include providing assistance
with medical utilization management, pharmacy management and specialist network development.
Additionally, we provide financial reports for our IPAs to further assist with their practices.
These services currently relate only to those patients served by the IPAs who are enrolled in
Humana health plans. We currently have 27 IPA relationships. As of June 30, 2005, our IPA
physicians provided services to approximately 725 patients on a full risk basis and to
approximately 7,600 patients on a limited or non-risk basis. Our IPAs practice primary care
medicine on an outpatient basis in facilities similar to our medical centers. Our IPA physicians
typically earn a capitated fee for providing the services and may be entitled to obtain bonus
distributions if they operate their practice in accordance with their negotiated contract. Most of
our IPA relationships, including most of our non-risk IPA relationships, are governed under the
Humana PGP Agreement. The initial term of the Humana PGP Agreement ended in March 2005, but the
term of the Humana PGP Agreement continues by its terms until the agreement is cancelled by either
party subject to prior notice. We are engaged in discussions with Humana regarding a possible
modification and extension of the Humana PGP Agreement, but it is not possible to predict at this
time whether we will ultimately agree to modify or agree to extend the Humana PGP Agreement.
Our HMO Affiliates
We currently have managed care agreements with Humana, Vista and Wellcare. In Fiscal 2005, we
generated approximately 78% of our net medical services revenue from Humana and approximately 22%
of our net medical services revenue from Vista. We continually review and attempt to renegotiate
the terms of our managed care agreements in an effort to obtain more favorable terms. We may
selectively add new HMO affiliations, but we can provide no assurance that we will be successful in
doing so. The loss of significant HMO contracts and/or the failure to regain or retain such HMOs
patients or the related revenues without entering into new HMO affiliations could have a material
adverse effect on our business results of operations and financial condition.
Humana
We currently have four agreements with Humana. However, the majority of the revenue that we
derive from our relationship with Humana is generated under the Humana POP Agreement. Under the
Humana POP Agreement we provide or arrange for the provision of covered medical services to each
Humana member who selects one of our physicians as his or her primary care physician. We receive a
capitated fee with respect to the patients assigned to us. For most of our Humana patients the
capitated fee is a percentage of the premium that Humana receives with respect to that patient.
The Humana POP Agreement is subject to Humanas changes to the covered benefits that it elects to
provide to its members and other terms and conditions. We must also comply with the terms of
Humanas policies and procedures, including Humanas policies regarding referrals, approvals and
utilization management and quality assessment.
The initial term of the Humana POP Agreement extends through July 31, 2008, unless terminated
earlier for cause, and, thereafter, the Humana POP Agreement renews for subsequent one-year terms
unless either party provides 180-days written notice of its intent not to renew. Humana may
immediately terminate the Humana POP Agreement, and/or any individual physician credentialed under
the Humana POP Agreement, upon written notice, (i) if we and/or any of our physicians continued
participation in the Humana POP Agreement may affect adversely the health, safety or welfare of any
Humana member; (ii) if we and/or any of our physicians continued participation in the Humana POP
Agreement may bring Humana or its health care networks into disrepute; (iii) in the event of one of
our doctors death or incompetence; (iv) if any of our physicians fail to meet Humanas
credentialing criteria; (v) in accordance with Humanas policies and procedures, (vi) if we engage
in or acquiesce to any act of bankruptcy, receivership or reorganization; or (vii) if Humana loses
its authority to do business in total or as to any limited segment or business (but only to that
segment). We and Humana may also each terminate the Humana POP Agreement upon 90 days prior
written notice (with an opportunity to cure, if possible) in the event of the others material
breach of the Humana POP Agreement.
12
In some cases, Humana may provide 30 days notice as to an amendment or modification of the
Humana POP Agreement, including but not limited to, renegotiation of rates, covered benefits and
other terms and conditions. Such amendments may include changes to the compensation rates. If
Humana exercises its right to amend the Humana POP Agreement upon 30 days written notice, we may
object to such amendment within the 30-day notice period. If we object to such amendment within
the requisite time frame, Humana may terminate the Humana POP Agreement upon 90 days written
notice.
One of our other agreements with Humana is the Humana PGP Agreement. Under the Humana PGP
Agreement, we agreed to assume certain management responsibilities on a non-risk basis for Humanas
Medicare, Commercial and Medicaid members assigned to selected primary care physicians in
Miami-Dade and Broward Counties, Florida, for a period of two years in return for a capitated fee
per patient. The Humana PGP Agreement relates to approximately 25 physicians that we service on a
non-risk basis. The initial term of the Humana PGP Agreement ended in March 2005, but the Humana
PGP Agreement continues by its terms until the agreement is cancelled by either party subject to
prior notice. We are engaged in discussions with Humana regarding a possible modification and
extension of the Humana PGP Agreement, but it is not possible to predict at this time whether we
will ultimately agree to modify or agree to extend the Humana PGP Agreement. In addition, any
modification or extension that we agree to may be on different terms and provide for different
obligations on the part of the respective parties than the terms and obligations currently provided
for in the Humana PGP Agreement.
Although the Humana PGP Agreement is not generally material to our business, in connection
with our entering into the Humana PGP Agreement we and Humana simultaneously cancelled a $3.9
million contract modification note payable to Humana, and, instead, the Humana PGP Agreement
contained a provision for liquidated damages in the amount of $4.0 million, which could be asserted
by Humana in certain circumstances. Under the terms of the Humana PGP Agreement, if we remained in
compliance with the terms of the agreement, Humana, at its option, could reduce the maximum amount
of liquidated damages at specified dates during the initial two-year term of the Humana PGP
Agreement. To the extent that Humana reduced the maximum amount of liquidated damages, a portion
of the deferred gain was recognized in a manner consistent with the reduction in the liquidated
damages. In Fiscal 2005, Humana notified us that the maximum amount of liquidated damages had been
reduced from $3.0 million to $0 and we recognized the entire remaining portion of the deferred
gain.
Vista
In November 2004, we entered into an Amended and Restated Primary Care Provider Services
agreement with Vista. The new agreement replaced our prior relationship with Vista. Under the new
agreement with Vista, we provide or arrange for the provision of covered medical services to each
Vista member who selects one of our physicians as his or her primary care physician. We receive a
capitated fee with respect to the Vista patients assigned to us. For commercial and individual
Vista patients the capitated fee will be a fixed monthly payment per member. For Medicare patients
the capitated fee will be a percentage of the premium that Vista receives with respect to those
patients. Our agreement with Vista is subject to Vistas changes to the covered benefits that
Vista elects to provide to its members and other terms and conditions. We must also comply with the
terms of Vistas policies and procedures, including Vistas policies regarding referrals, approvals
and utilization management and quality assessment.
The agreement runs through June 30, 2008 (unless earlier terminated in accordance with its
terms) and will thereafter automatically renew for successive one year periods unless either party
provides the other with 180 days notice of its intent to terminate the agreement. Vista may
terminate the agreement with us immediately if we materially breach the agreement, provided that we
are given an opportunity to cure such breach, and if we experience certain events of bankruptcy or
insolvency. In addition, Vista may immediately terminate the agreement if Vista determines, in its
sole reasonable discretion, that (i) our actions or inactions or those of our health care
professionals are causing or may cause imminent danger to the health, safety or welfare of any
Vista member; (ii) our or our health care professionals licenses, DEA registrations, hospital
staff privileges, rights to participate in the Medicare or Medicaid program or other accreditations
are restricted, suspended or revoked or if any of our health care professionals voluntarily
relinquish any of those credentials and we do not promptly terminate that professional; (iii) our
health care professionals ability to practice medicine is effectively impaired by an action of the
Board of Medicine or other governmental agency; (iv) we are convicted of a criminal offense related
to our involvement in Medicaid, Medicare or social service programs under Title XX of the Social
Security Act; or (v) we or our medical professionals engaged in any other behavior or activity that
could be hazardous or injurious to any Vista member.
Wellcare
Effective September 1, 2004, we entered into a Physician Provider Agreement with Wellcare
under which we provide or
arrange for the provision of covered medical services to each Wellcare member who selects one
of our physicians as his or her primary care physician. To date we have not received meaningful
revenue under our agreement with Wellcare.
13
Under our agreements with Humana, Vista and Wellcare, there exist circumstances under which we
could be obligated to continue to provide medical services to patients in our care following a
termination of the applicable agreement. In certain cases, this obligation could require us to
provide care to patients following the bankruptcy or insolvency of our HMO affiliate. Accordingly,
our obligations to provide medical services to our patients (and the associated costs we incur) may
not terminate at the time that our agreement with the HMO terminates, and we may not be able to
recover our cost of providing those services from the HMO.
Compliance Program
We have implemented a compliance program intended to provide ongoing monitoring and reporting
to detect and correct potential regulatory compliance problems but we cannot assure that it will
detect or prevent all regulatory problems. The program establishes compliance standards and
procedures for employees and agents. The program includes, among other things: written policies,
including our Code of Conduct and Ethics; in-service training for our employees on topics such as
insider trading, anti-kickback laws, Federal False Claims Act and Anti-Self Referral Act; and a
hot line for employees to anonymously report violations.
Competition
The health care industry is highly competitive. We compete for patients with many other
health care providers, including local physicians and practice groups as well as local, regional
and national networks of physicians and health care companies. We believe that competition for
patients is generally based upon the reputation of the physician treating the patient, the
physicians expertise, the physicians demeanor and manner of engagement with the patient, and the
HMOs that the physician is affiliated with. We also compete with other local, regional and
national networks of physicians and health care companies for the services of physicians and for
HMO affiliations. Some of our competitors have greater resources than we do, and we may not be
able to continue to compete effectively in this industry. Further, additional competitors may
enter our markets, and this increased competition may have an adverse effect on our revenues.
Government Regulation
General. Our business is regulated by the federal government and the State of Florida. The
laws and regulations governing our operations are generally intended to benefit and protect health
plan members and providers rather than shareholders. The government agencies administering these
laws and regulations have broad latitude to enforce them. These laws and regulations, along with
the terms of our contracts, regulate how we do business, what services we offer, and how we
interact with our members, other providers and the public. We are subject to various governmental
reviews, audits and investigations to verify our compliance with our contracts and applicable laws
and regulations.
A summary of the material aspects of the government regulations to which we are subject is set
forth below. However, there can be no assurance that any such laws will not change or ultimately
be interpreted in a manner inconsistent with our practices, and an adverse interpretation could
have a material adverse effect on our results of operations, financial condition or cash flows.
Present and Prospective Federal and State Reimbursement Regulation. Our operations are
affected on a day-to-day basis by numerous legislative, regulatory and industry-imposed operational
and financial requirements, which are administered by a variety of federal and state governmental
agencies as well as by self-regulatory associations and commercial medical insurance reimbursement
programs. We have filed for all our physicians the necessary reassignments of billing rights
applications with Medicare.
Federal Fraud and Abuse Laws and Regulations. The Anti-Kickback Law makes it a criminal
felony offense to knowingly and willfully offer, pay, solicit or receive remuneration in order to
induce business for which reimbursement is provided under federal health care programs, including
without limitation, the Medicare and Medicaid programs. Violations of these laws are punishable by
monetary fines, civil and criminal penalties, exclusion from care programs and forfeiture of
amounts collected in violation of such laws. The scope of prohibited payments in the Anti-Kickback
Law is broad and includes economic arrangements involving hospitals, physicians and other health
care providers, including joint ventures, space and equipment rentals, purchases of physician
practices and management and personal services contracts.
State Fraud and Abuse Regulations. Various states also have anti-kickback laws applicable to
licensed healthcare professionals and other providers and, in some instances, applicable to any
person engaged in the proscribed conduct. For example, Florida enacted The Patient Brokering Act
which imposes criminal penalties, including jail terms and fines, for receiving or paying any
commission, bonus, rebate, kickback, or bribe, directly or indirectly in cash or in kind, or engage
in any split-fee arrangement, in
any form whatsoever, to induce the referral of patients or patronage from a healthcare
provider or healthcare facility. The Florida statutory provisions regulating the practice of
medicine include similar language as grounds for disciplinary action against a physician.
14
Restrictions on Physician Referrals. Federal regulations under the Social Security Act that
restrict physician referrals to health care entities with which they have financial relationships
(commonly referred to as the Stark Law) prohibit certain patient referrals by physicians.
Specifically, the Stark Law prohibits a physician, or an immediate family member, who has a
financial relationship with a health care entity, from referring Medicare or Medicaid patients with
limited exceptions, to that entity for the following designated health services: clinical
laboratory services, physical therapy services, occupational therapy services, speech-language
pathology services, radiology services, including magnetic resonance imaging, computerized axial
tomography scans and ultrasound services, speech-language pathology services, durable medical
equipment and supplies, radiation therapy services and supplies, parenteral and enteral nutrients,
equipment and supplies, prosthetics, orthotics and prosthetic devices, home health services,
outpatient prescription drugs, and inpatient and outpatient hospital services. A financial
relationship is defined to include an ownership or investment in, or a compensation relationship
with, a health care entity. The Stark Law also prohibits a health care entity receiving a
prohibited referral from billing the Medicare or Medicaid programs for any services rendered to a
patient as a result of the prohibited referral. The Stark Law contains certain exceptions that
protect parties from liability if the parties comply with all of the requirements of the applicable
exception. The sanctions under the Stark Law include denial and refund of payments, civil monetary
penalties and exclusions from participation in the Medicare and Medicaid programs.
The Florida Patient Self Referral Act of 1992 (Florida Act) regulates patient referrals by a
health care provider to certain providers of health care services in which the referring provider
has an investment interest. Unlike the federal Stark regulations, the Florida act applies only to
investment interests and does not affect compensation relationships between the referring provider
and the entity to which the provider is referring patients. The penalties for breach of the
Florida Act include denial and refund of claims payments and civil monetary penalties.
Privacy Laws. The privacy, security and transmission of health information is subject to
federal and state laws and regulations, including the Healthcare Insurance Portability and
Accountability Act of 1996 (HIPAA) and regulations enacted under HIPAA with respect to, among
other things, the privacy of certain individually identifiable health information, the transmission
of protected health information and standards for the security of electronic health information.
Corporate Practice of Medicine Doctrine. Many states prohibit business corporations from
providing, or holding themselves out as a provider of medical care. Possible sanctions for
violation of any of these restrictions or prohibitions include loss of licensure or eligibility to
participate in reimbursement programs (including Medicare and Medicaid), asset forfeitures and
civil and criminal penalties. These laws vary from state to state, are often vague and loosely
interpreted by the courts and regulatory agencies. Currently, we only operate in Florida, which
does not have a corporate practice of medicine doctrine with respect to the types of physicians
employed with us.
Clinic Licensure. The State of Florida Agency for Health Care Administration requires us to
license each of our medical centers individually as health care clinics. Each medical center must
renew its health care clinic licensure bi-annually.
Limitations on Contractual Joint Ventures. The Office of Inspector General (OIG) issued a
Special Advisory Bulletin raising concerns throughout the healthcare industry about the legality of
a variety of provider joint ventures. The suspect arrangements involve a healthcare provider
expanding into a related service line by contracting with an existing provider of that service to
serve the providers existing patient population. In the OIGs view, the providers share of the
profits of the new venture constitutes remuneration for the referral of the providers
Medicare/Medicaid patients and thus may violate the federal Anti-kickback Statute.
Occupational Safety and Health Administration (OSHA). In addition to OSHA regulations
applicable to businesses generally, we must comply with, among other things, the OSHA directives on
occupational exposure to blood borne pathogens, the federal Needlestick Safety and Prevention Act,
OSHA injury and illness recording and reporting requirements, federal regulations relating to
proper handling of laboratory specimens, spill procedures and hazardous waste disposal, and patient
transport safety requirements.
Medicare Marketing Restrictions. As a health care provider, we are subject to federal
marketing rules and regulations that limit, among other things, offering any gift or other
inducement to Medicare beneficiaries to encourage them to come to us for their health care.
Sanctioned Parties. The Balanced Budget Act of 1997 (BBA) includes provisions that allow
for the temporary or permanent exclusion from participation in Medicare or any state health care
program of any individual or entity who or which has been convicted of a health care related crime
as well as specified. The BBA also provides for fines against any person that arranges or
contracts with an excluded person for the provision of items or services.
Healthcare Reform. The federal government from time to time explores ways to reduce medical
care cost through Medicare
15
reform and through healthcare reform, generally. Any changes that would
limit, reduce or delay receipt of Medicare funding or any developments that would disqualify us
from receiving Medicare funding could have a material adverse effect on our business, results of
operations, prospects, financial results, financial condition or cash flows. Due to the diverse
range of proposals put forth and the uncertainty of any proposals adoption, we cannot predict what
impact any Medicare reform proposal ultimately adopted may have on our business, financial position
or results of operations.
Employees
At June 30, 2005, we employed or contracted with approximately 255 individuals of whom
approximately 32 are physicians in our medical centers.
Insurance
We rely on insurance to protect us from many business risks, including medical malpractice and
stop-loss insurance. Our business entails an inherent risk of claims against physicians for
professional services rendered to patients, and we periodically become involved as a defendant in
medical malpractice lawsuits. Medical malpractice claims are subject to the attendant risk of
substantial damage awards. Although we maintain insurance against these claims, if liability
results from any of our pending or any future medical malpractice claims, there can be no assurance
that our medical malpractice insurance coverage will be adequate to cover liability arising out of
these proceedings. There can be no assurance that pending or future litigation will not have a
material adverse affect on us or that liability resulting from litigation will not exceed our
insurance coverage.
In most cases, as is the trend in the health care industry, as insurance policies expire, we
may be required to procure policies with narrower coverage, more exclusions and higher premiums. In
some cases, coverage may not be available at any price. There can be no assurance that the
insurance that we maintain and intend to maintain will be adequate, or that the cost of insurance
and limitations in coverage will not adversely affect our business, financial position or results
of operations.
Available Information
We file annual, quarterly and special reports, proxy statements and other information with the
SEC. You may read and copy any document we file at the SECs public reference rooms in Washington,
D.C., New York, New York, and Chicago, Illinois. Please call the SEC at 1-800-SEC-0330 for further
information on the public reference rooms. Our SEC filings are also available to the public from
the SECs website at http://www.sec.gov. In addition, you can inspect the reports, proxy
statements and other information we file at the offices of the American Stock Exchange, Inc., 86
Trinity Place, New York, New York 10006.
Our website address is www.continucare.com. We make available free of charge on or through
our internet website our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K and amendments to those reports, filed or furnished pursuant to Section 13(a)
or 15(d) of the Securities Exchange Act of 1934 as soon as reasonably practicable after such
material has been filed with, or furnished to, the SEC. Our website does not constitute part of
this Annual Report on Form 10-K.
ITEM 2. PROPERTIES
We lease approximately 9,800 square feet of space in Miami, Florida under a lease expiring in
December 2009 with average annual base lease payments of approximately $161,000.
Of the 15 medical centers that we operated as of June 30, 2005, five are leased from
independent landlords and the other 10 clinics are leased from Humana. The leases with Humana are
tied to our managed care arrangement.
ITEM 3. LEGAL PROCEEDINGS
We are a party to the case of JOAN LINDAHL v. HUMANA MEDICAL PLAN, INC., COLUMBIA HOSPITAL
CORPORATION OF SOUTH BROWARD d/b/a WESTSIDE REGIONAL MEDICAL CENTER, INPHYNET CONTRACTING SERVICES,
INC., CONTINUCARE MEDICAL MANAGEMENT, INC., LUIS GUERRERO AND JARSLAW PARKOLAP. This case was
filed on January 24, 2002 in the Circuit Court of the 17th Judicial Circuit in and for
Broward County, Florida and served on the companies and individuals in February 2003. The
complaint alleges vicarious liability for medical malpractice and seeks damages
in excess of $15,000. We intend to defend ourselves against this case vigorously, but its
outcome cannot be predicted. Our ultimate liability, if any, with respect to the lawsuit is
presently not determinable.
We are a party to the case of MAUREEN MCCANN, AS PERSONAL REPRESENTATIVE OF THE ESTATE OF
16
WALTER MCCANN v. AJAIB MANN, M.D. AND CONTINUCARE CORPORATION. This case was filed on April 5,
2005, in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida.
The complaint alleges vicarious liability for medical malpractice. We intend to defend ourselves
against this case vigorously, but its outcome cannot be predicted. Our ultimate liability, if any,
with respect to the lawsuit is presently not determinable.
In May 2005, we received a Notice of Intent to Initiate Litigation for Medical Negligence from
legal counsel to a former patient. In July 2005, the Notice of Intent to Initiate Litigation for
Medical Negligence was withdrawn.
We are also involved in other legal proceedings incidental to our business that arise from
time to time out of the ordinary course of business including, but not limited to, claims related
to the alleged malpractice of employed and contracted medical professionals, workers compensation
claims and other employee-related matters, and minor disputes with equipment lessors and other
vendors. We have recorded an accrual for medical malpractice claims, which includes amounts for
insurance deductibles and projected exposure, based on our estimate of the ultimate outcome of such
claims.
|
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS |
Not applicable.
PART II
ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
Our common stock is traded on the American Stock Exchange (AMEX) under the symbol CNU.
The following table sets forth the high and low sale prices of our common stock as reported by the
composite tape of AMEX for each of the quarters indicated.
|
|
|
|
|
|
|
|
|
|
|
HIGH |
|
|
LOW |
|
Fiscal Year 2005 |
|
|
|
|
|
|
|
|
Quarter Ended 9/30/04 |
|
$ |
1.98 |
|
|
$ |
1.29 |
|
Quarter Ended 12/31/04 |
|
|
2.54 |
|
|
|
1.45 |
|
Quarter Ended 3/31/05 |
|
|
2.80 |
|
|
|
1.80 |
|
Quarter Ended 6/30/05 |
|
|
3.55 |
|
|
|
2.21 |
|
|
|
|
|
|
|
|
|
|
Fiscal Year 2004: |
|
|
|
|
|
|
|
|
Quarter Ended 9/30/03 |
|
$ |
0.82 |
|
|
$ |
0.39 |
|
Quarter Ended 12/31/03 |
|
|
1.95 |
|
|
|
0.66 |
|
Quarter Ended 3/31/04 |
|
|
3.18 |
|
|
|
1.30 |
|
Quarter Ended 6/30/04 |
|
|
3.00 |
|
|
|
1.59 |
|
As of the close of business on September 1, 2005, there were approximately 138 record holders
of our common stock. We have not paid dividends on our common stock and do not contemplate paying
dividends in the foreseeable future.
17
Securities Authorized for Issuance Under Equity Compensation Plans
The following table provides information as of June 30, 2005, with respect to all of our
compensation plans under which equity securities are authorized for issuance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of securities to |
|
|
Weighted average |
|
|
|
|
|
|
be issued upon exercise |
|
|
exercise price of |
|
|
Number of securities |
|
|
|
of outstanding options, |
|
|
outstanding options, |
|
|
remaining available |
|
Plan Category |
|
warrants and rights |
|
|
warrants and rights |
|
|
for future issuance |
|
Plans approved by stockholders |
|
|
3,814,000 |
|
|
|
$1.22 |
|
|
|
4,883,334 |
|
Plans not approved by
stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,814,000 |
|
|
|
|
|
|
|
4,883,334 |
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
In May 2005, we announced that we had increased our previously announced stock repurchase
program to authorize the buy back of up to 2,500,000 shares of our common stock. Any such
repurchases will be made from time to time at the discretion of our management in the open market
or in privately negotiated transactions subject to market conditions and other factors. We
anticipate that any such repurchases of shares will be funded through cash from operations. There
is no expiration date specified for this program. The following table provides information with
respect to our stock repurchases during the fourth quarter of Fiscal 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number of |
|
|
Maximum Number of |
|
|
|
|
|
|
|
|
|
|
|
Shares Purchased as |
|
|
Shares that May Yet Be |
|
|
|
Total Number of |
|
|
Average Price Paid |
|
|
Part of Publicly |
|
|
Purchased Under the |
|
Period |
|
Shares Purchased |
|
|
per Share |
|
|
Announced Plan |
|
|
Plan |
|
April 1 to April 30, 2005 |
|
|
153,700 |
|
|
|
$2.47 |
|
|
|
153,700 |
|
|
|
2,196,500 |
|
May 1 to May 31, 2005 |
|
|
422,500 |
|
|
|
$2.58 |
|
|
|
422,500 |
|
|
|
1,774,000 |
|
June 1 to June 30, 2005 |
|
|
149,700 |
|
|
|
$2.72 |
|
|
|
149,700 |
|
|
|
1,624,300 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
|
725,900 |
|
|
|
$2.60 |
|
|
|
725,900 |
|
|
|
|
|
ITEM 6. SELECTED FINANCIAL DATA
Set forth below is our selected historical consolidated financial data as of and for Fiscal
2005, 2004, 2003, 2002 and 2001 that has been derived from our audited consolidated financial
statements. The selected historical consolidated financial data should be read in conjunction with
Managements Discussion and Analysis of Financial Condition and Results of Operations and the
consolidated financial statements and accompanying notes included elsewhere herein.
18
CONSOLIDATED STATEMENTS OF OPERATIONS DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended June 30, |
|
|
2005 |
|
2004 (1) |
|
2003 (1) |
|
2002 (1) |
|
2001 (1) |
|
|
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical services revenue, net |
|
$ |
111,316,174 |
|
|
$ |
101,123,346 |
|
|
$ |
97,164,834 |
|
|
$ |
90,978,930 |
|
|
$ |
85,824,012 |
|
Management fee revenue and other income |
|
|
914,939 |
|
|
|
700,756 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
|
112,231,113 |
|
|
|
101,824,102 |
|
|
|
97,164,834 |
|
|
|
90,978,930 |
|
|
|
85,824,012 |
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical services: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical claims |
|
|
81,104,665 |
|
|
|
76,333,580 |
|
|
|
74,046,265 |
|
|
|
69,340,067 |
|
|
|
68,620,251 |
|
Other direct costs |
|
|
12,648,297 |
|
|
|
11,665,894 |
|
|
|
10,696,997 |
|
|
|
10,395,210 |
|
|
|
10,610,660 |
|
|
|
|
Total medical services |
|
|
93,752,962 |
|
|
|
87,999,474 |
|
|
|
84,743,262 |
|
|
|
79,735,277 |
|
|
|
79,230,911 |
|
Administrative payroll and employee benefits |
|
|
5,107,672 |
|
|
|
3,822,949 |
|
|
|
3,681,446 |
|
|
|
2,689,562 |
|
|
|
3,137,722 |
|
General and administrative |
|
|
7,059,602 |
|
|
|
5,821,871 |
|
|
|
6,252,347 |
|
|
|
6,446,444 |
|
|
|
8,118,992 |
|
Gain on extinguishment of debt |
|
|
(3,000,000 |
) |
|
|
(850,000 |
) |
|
|
|
|
|
|
|
|
|
|
(3,503,188 |
) |
|
|
|
Total operating expenses |
|
|
102,920,236 |
|
|
|
96,794,294 |
|
|
|
94,677,055 |
|
|
|
88,871,283 |
|
|
|
86,984,437 |
|
|
|
|
Income (loss) from operations |
|
|
9,310,877 |
|
|
|
5,029,808 |
|
|
|
2,487,779 |
|
|
|
2,107,647 |
|
|
|
(1,160,425 |
) |
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
108,000 |
|
|
|
4,793 |
|
|
|
6,568 |
|
|
|
36,124 |
|
|
|
32,342 |
|
Interest expense |
|
|
(702,946 |
) |
|
|
(1,006,082 |
) |
|
|
(956,327 |
) |
|
|
(1,567,479 |
) |
|
|
(1,624,116 |
) |
Medicare settlement related to terminated
operations |
|
|
|
|
|
|
2,218,278 |
|
|
|
|
|
|
|
(2,440,971 |
) |
|
|
|
|
|
|
|
Income (loss) from continuing operations before
income tax benefit |
|
|
8,715,931 |
|
|
|
6,246,797 |
|
|
|
1,538,020 |
|
|
|
(1,864,679 |
) |
|
|
(2,752,199 |
) |
Income tax benefit |
|
|
7,175,561 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
15,891,492 |
|
|
|
6,246,797 |
|
|
|
1,538,020 |
|
|
|
(1,864,679 |
) |
|
|
(2,752,199 |
) |
Income (loss) from discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home health operations |
|
|
|
|
|
|
(1,666,934 |
) |
|
|
(1,830,118 |
) |
|
|
(1,295,310 |
) |
|
|
(541,251 |
) |
Terminated IPAs |
|
|
|
|
|
|
73,091 |
|
|
|
350,696 |
|
|
|
(486,399 |
) |
|
|
(1,482,657 |
) |
Contractual revision of previously recorded
medical claims and other liabilities from
discontinued operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,638,205 |
|
|
|
|
Total income (loss) from discontinued operations |
|
|
|
|
|
|
(1,593,843 |
) |
|
|
(1,479,422 |
) |
|
|
(1,781,709 |
) |
|
|
2,614,297 |
|
|
|
|
Net income (loss) |
|
$ |
15,891,492 |
|
|
$ |
4,652,954 |
|
|
$ |
58,598 |
|
|
$ |
(3,646,388 |
) |
|
$ |
(137,902 |
) |
|
|
|
Basic net income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
.32 |
|
|
$ |
.14 |
|
|
$ |
.04 |
|
|
$ |
(.05 |
) |
|
$ |
(.08 |
) |
Loss from discontinued operations |
|
|
|
|
|
|
(.03 |
) |
|
|
(.04 |
) |
|
|
(.04 |
) |
|
|
.08 |
|
|
|
|
Net income (loss) per common share |
|
$ |
.32 |
|
|
$ |
.11 |
|
|
$ |
|
|
|
$ |
(.09 |
) |
|
|
|
|
|
|
|
Diluted net income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
.31 |
|
|
$ |
.12 |
|
|
$ |
.04 |
|
|
$ |
(.05 |
) |
|
$ |
(.08 |
) |
Loss from discontinued operations |
|
|
|
|
|
|
(.03 |
) |
|
|
(.04 |
) |
|
|
(.04 |
) |
|
|
.08 |
|
|
|
|
Net income (loss) per common share |
|
$ |
.31 |
|
|
$ |
.09 |
|
|
$ |
|
|
|
$ |
(.09 |
) |
|
$ |
|
|
|
|
|
Cash dividends declared |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
CONSOLIDATED BALANCE SHEET DATA:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, |
|
|
|
2005 |
|
|
2004 |
|
|
2003 (1) |
|
|
2002 (1) |
|
|
2001 (1) |
|
|
|
|
Total assets |
|
$ |
34,137,935 |
|
|
$ |
21,908,181 |
|
|
$ |
20,999,976 |
|
|
$ |
21,546,985 |
|
|
$ |
22,343,279 |
|
Long-term obligations, including current portion |
|
$ |
107,710 |
|
|
$ |
337,186 |
|
|
$ |
9,597,063 |
|
|
$ |
13,877,505 |
|
|
$ |
11,806,623 |
|
|
|
|
(1) |
|
These amounts have been adjusted to reflect the termination of certain lines of business, discussed in Note 3 in the
accompanying Consolidated Financial Statements, as discontinued operations. |
19
ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
General
The following discussion and analysis should be read in conjunction with the consolidated
financial statements and notes thereto appearing elsewhere in this annual report. We are a mixed
model provider of primary care physician services. Through our network of 15 medical centers and
27 IPAs located in Miami-Dade, Broward and Hillsborough Counties, Florida, we were responsible for
providing primary care medical services or overseeing the provision of primary care services by
affiliated physicians to approximately 13,600 patients on a full risk basis and approximately
14,400 patients on a limited or non-risk basis as of June 30, 2005. In Fiscal 2005, approximately
95% of our revenue was generated by providing services to Medicare-eligible members under full risk
agreements that require us to assume responsibility to provide and pay for all of our patients
medical needs in exchange for a capitated fee, typically a percentage of the premium received by an
HMO from various payor sources.
In an effort to streamline and stem operating losses, effective January 1, 2003, we terminated
the Medicare and Medicaid lines of business for all of the physician contracts associated with one
of our IPAs, which consisted of 29 physicians at the time of termination. Additionally, in
December 2003, we implemented a plan to dispose of our home health operations. The home health
disposition occurred in three separate transactions and was concluded on February 7, 2004. As a
result of these transactions, the operations of the terminated IPAs and our home health operations
are shown as discontinued operations.
Restatement
Our consolidated financial statements as of and for Fiscal 2004 have been restated to give
effect to the financial impact of a latent error in an automated software system used to submit
particular patient data to one of our HMO affiliates. Because the data submitted through the
software in question formed an element of the HMOs calculation of payments due to us, the error
resulted in us over-stating revenue associated with that one HMO beginning in the fourth quarter of
Fiscal 2004. The softwares use was confined to the one HMO. Accordingly, the error did not
impact revenue associated with any of our other HMO affiliates and had no effect on our financial
position or results of operations as of and for the year ended June 30, 2003. The restatement
reduced previously reported revenue and net income for Fiscal 2004 by approximately $0.6 million,
or $0.02 per basic and diluted common share. The restatement also reduced the amount previously
reported as due from HMOs at June 30, 2004 by approximately $0.6 million. The following discussion
has been updated to give effect to this restatement.
Medicare Considerations
Substantially all of our net medical services revenue from continuing operations is based upon
Medicare funded programs. The federal government and state governments, including Floridas, from
time to time explores ways to reduce medical care costs through Medicare reform and through health
care reform generally. Any changes that would limit, reduce or delay receipt of Medicare funding
or that would increase the benefits we are required to provide to Medicare patients without a
corresponding increase in the amounts we are paid for our services or any developments that would
disqualify us from receiving Medicare funding could have a material adverse effect on our business,
results of operations, prospects, financial results, financial condition or cash flows. Due to the
diverse range of proposals put forth and the uncertainty of any proposals adoption, we cannot
predict what impact any Medicare reform proposal ultimately adopted may have on our business,
financial position or results of operations.
Critical Accounting Policies and Estimates
The discussion and analysis of our financial condition and results of operations is based upon
our consolidated financial statements and accompanying notes, which have been prepared in
accordance with accounting principles generally accepted in the United States of America. The
preparation of these financial statements and accompanying notes requires us to make estimates and
assumptions that affect the amounts reported in the financial statements and accompanying notes.
Certain of the amounts recorded on our financial statements could change materially under
different, yet still reasonable, estimates and assumptions. We base our estimates and assumptions
on historical experience, knowledge of current events and expectations of future events, and we
continuously evaluate and update our estimates and assumptions. However, our estimates and
assumptions may ultimately prove to be incorrect or incomplete and, as a result, our actual results
may differ materially from those previously reported. We believe the following critical accounting
policies involve the most significant judgments and estimates used in the preparation of our
consolidated financial statements.
20
Revenue Recognition
Under our full risk contracts with HMOs, we receive a percentage of premium or other capitated
fee for each patient that chooses one of our physicians as their primary care physician. Revenue
under these agreements is generally recorded in the period services are rendered at the rates then
in effect as determined by the respective contract. As part of the Medicare Advantage program, CMS
periodically recomputes the premiums to be paid to the HMOs based on updated health status of
participants and updated demographic factors. We record any adjustments to this revenue at the
time that the information necessary to make the determination of the adjustment is received from
the HMO or CMS.
Under our full risk agreements, we assume responsibility for the cost of all medical services
provided to the patient, even those we do not provide directly, in exchange for a percentage of
premium or other capitated fee. To the extent that patients require more frequent or expensive
care, our revenue under a contract may be insufficient to cover the costs of care provided. When
it is probable that expected future health care costs and maintenance costs under a contract or
group of existing contracts will exceed anticipated capitated revenue on those contracts, we
recognize losses on our prepaid health care services with HMOs. No contracts were considered loss
contracts at June 30, 2005 because we have the right to terminate unprofitable physicians and close
unprofitable centers under our managed care contracts.
Under our limited risk and no-risk contracts with HMOs, we receive a management fee based on
the number of patients for which we are providing services on a monthly basis. The management fee
is recorded as revenue in the period in which services are provided as determined by the respective
contract.
Medical Claims Expense Recognition
The cost of health care services provided or contracted for is accrued in the period in which
the services are provided. This cost includes our estimate of the related liability for medical
claims incurred in the period but not yet reported, or IBNR. IBNR represents a material portion of
our medical claims liability which is presented in the balance sheet net of amounts due from HMOs.
Changes in this estimate can materially affect, either favorably or unfavorably, our results from
operations and overall financial position.
We develop our estimate of IBNR primarily based on historical claims incurred per member per
month. We adjust our estimate if we have unusually high or low inpatient utilization or if benefit
changes provided under the HMO plans are expected to significantly increase or reduce our claims
exposure. We also adjust our estimate for differences between the estimated claims expense
recorded in prior months to actual claims expense as claims are paid by the HMO and reported to us.
To further corroborate our estimate of medical claims, an independent actuarial calculation is
performed for us on a quarterly basis. This independent actuarial calculation indicates that IBNR
as of June 30, 2005 was between approximately $11.2 million and $12.4 million. Based on our
internal analysis and the independent actuarial calculation, as of June 30, 2005, we recorded a
liability of approximately $11.7 million for IBNR.
Consideration of Impairment Related to Goodwill and Other Intangible Assets
Our balance sheet includes intangible assets, including goodwill and other separately
identifiable intangible assets, which represented approximately 45% of our total assets at June 30,
2005. Under Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible
Assets, goodwill and intangible assets with indefinite useful lives are no longer amortized, but
are reviewed for impairment on an annual basis or more frequently if certain indicators of
permanent impairment arise. Intangible assets with definite useful lives are amortized over their
respective useful lives to their estimated residual values and also reviewed for impairment
annually, or more frequently if certain indicators of permanent impairment arise. Indicators of a
permanent impairment include, among other things, a significant adverse change in legal factors or
the business climate, the loss of a key HMO contract, an adverse action by a regulator,
unanticipated competition, the loss of key personnel or allocation of goodwill to a portion of
business that is to be sold.
Because we operate in a single segment of business, we have determined that we have a single
reporting unit and we perform our impairment test for goodwill on an enterprise level. In
performing the impairment test, we compare the total current market value of all of our outstanding
common stock, to the current carrying value of our total net assets, including goodwill and
intangible assets. Depending on the market value of our common stock at the time that an
impairment test is required, there is a risk that a portion of our intangible assets would be
considered impaired and must be written-off during that period. We completed our annual impairment
test on May 1, 2005, and determined that no indicators of impairment existed. Accordingly, no
impairment charges were required at June
21
30, 2005. Should we later determine that an indicator of impairment exists, we would be
required to perform an additional impairment test.
Realization of Deferred Tax Assets
We account for income taxes in accordance with Statement of Financial Accounting Standards No.
109, Accounting for Income Taxes (SFAS 109) which requires that deferred tax assets and
liabilities be recognized using enacted tax rates for the effect of temporary differences between
the book and tax bases of recorded assets and liabilities. SFAS No. 109 also requires that
deferred tax assets be reduced by a valuation allowance if it is more likely than not that some
portion or all of the deferred tax asset will not be realized.
As part of the process of preparing our consolidated financial statements, we estimate our
income taxes based on our actual current tax exposure together with assessing temporary differences
resulting from differing treatment of items for tax and accounting purposes. We also recognize as
deferred tax assets the future tax benefits from net operating loss carryforwards. We evaluate the
realizability of these deferred tax assets by assessing their valuation allowances and by adjusting
the amount of such allowances, if necessary. Among the factors used to assess the likelihood of
realization are our projections of future taxable income streams, the expected timing of the
reversals of existing temporary differences, and the impact of tax planning strategies that could
be implemented to avoid the potential loss of future tax benefits. However, changes in tax codes,
statutory tax rates or future taxable income levels could materially impact our valuation of tax
accruals and assets and could cause our provision for income taxes to vary significantly from
period to period.
At June 30, 2005, we had deferred tax assets in excess of deferred tax liabilities of
approximately $7.3 million. During Fiscal 2005, we determined that it is more likely than not that
those assets will be realized (although realization is not assured), resulting in no valuation
allowance at June 30, 2005.
Results of Operations
The following tables set forth, for the periods indicated, selected operating data as a
percentage of total revenue.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30, |
|
|
2005 |
|
2004 |
|
2003 |
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
Medical services revenue, net |
|
|
99.2 |
% |
|
|
99.3 |
% |
|
|
100.0 |
% |
Management fee revenue and other income |
|
|
0.8 |
|
|
|
0.7 |
|
|
|
|
|
|
|
|
Total revenue |
|
|
100.0 |
|
|
|
100.0 |
|
|
|
100.0 |
|
|
|
|
Operating
expenses: |
|
|
Medical services: |
|
|
|
|
|
|
|
|
|
|
|
|
Medical claims |
|
|
72.3 |
|
|
|
75.0 |
|
|
|
76.2 |
|
Other direct costs |
|
|
11.2 |
|
|
|
11.4 |
|
|
|
11.0 |
|
|
|
|
Total medical services |
|
|
83.5 |
|
|
|
86.4 |
|
|
|
87.2 |
|
Administrative payroll and employee benefits |
|
|
4.6 |
|
|
|
3.8 |
|
|
|
3.8 |
|
General and administrative |
|
|
6.3 |
|
|
|
5.7 |
|
|
|
6.4 |
|
Gain on extinguishment of debt |
|
|
(2.7 |
) |
|
|
(0.8 |
) |
|
|
|
|
|
|
|
Total operating expenses |
|
|
91.7 |
|
|
|
95.1 |
|
|
|
97.4 |
|
|
|
|
Income from operations |
|
|
8.3 |
|
|
|
4.9 |
|
|
|
2.6 |
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
0.1 |
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(0.6 |
) |
|
|
(1.0 |
) |
|
|
(1.0 |
) |
Medicare settlement related to terminated operations |
|
|
|
|
|
|
2.2 |
|
|
|
|
|
|
|
|
Income from continuing operations before income tax
benefit |
|
|
7.8 |
|
|
|
6.1 |
|
|
|
1.6 |
|
Income tax benefit |
|
|
6.4 |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
14.2 |
|
|
|
6.1 |
|
|
|
1.6 |
|
Income (loss) from discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
Home health operations |
|
|
|
|
|
|
(1.6 |
) |
|
|
(1.9 |
) |
Terminated IPAs |
|
|
|
|
|
|
0.1 |
|
|
|
0.4 |
|
|
|
|
Total loss from discontinued operations |
|
|
|
|
|
|
(1.5 |
) |
|
|
(1.5 |
) |
|
|
|
Net income |
|
|
14.2 |
% |
|
|
4.6 |
% |
|
|
0.1 |
% |
|
|
|
22
COMPARISON OF FISCAL YEAR ENDED JUNE 30, 2005 TO FISCAL YEAR ENDED JUNE 30, 2004
Revenue from Continuing Operations
Medical services revenue increased by $10.2 million, or 10.1%, to $111.3 million for Fiscal
2005 from $101.1 million for Fiscal 2004. The increase in our medical services revenue was
primarily the result of increases in our Medicare revenue, partially offset by a decrease in
commercial revenue of approximately $1.9 million which resulted primarily from the conversion of
certain commercial members of an HMO from a risk arrangement to a non-risk arrangement during
Fiscal 2005.
The most significant component of our medical services revenue is the revenue we generate from
Medicare patients under full risk arrangements. During Fiscal 2005, revenue generated by our
Medicare full risk arrangements increased approximately 18.0% on a per patient per month basis as
compared to Fiscal 2004, but this increase was partially offset by a decrease of approximately 4.7%
in Medicare patient months from Fiscal 2004. The increase in Medicare revenue was primarily due to
higher per patient per month premiums resulting from the Medicare Modernization Act and the
increased phase-in of the Medicare risk adjustment program, both of which became effective in
January 2004. Our Fiscal 2005 medical services revenue also included an additional $1.1 million of
Medicare Advantage funding that we received from an HMO in December 2004 and Medicare risk
adjustments of approximately $2.0 million that we earned during the third and fourth quarters of
Fiscal 2005 that we expect to collect in the quarter ended December 31, 2005. Under the Medicare
risk adjustment program, the health status of Medicare Advantage participants is taken into account
in determining premiums paid for each participant rather than considering only demographic factors,
as was historically the case. CMS periodically recomputes the premiums to be paid to the HMOs
based on updated health status of participants and updated demographic factors. Future Medicare
risk adjustments may result in reductions of revenue depending on the future health status and
demographic factors of our patients.
Management fee revenue and other income of $0.9 million and $0.7 million for Fiscal 2005 and
2004, respectively, related primarily to revenue generated under our limited risk and non-risk
contracts under the Humana PGP Agreement.
Revenue from continuing operations generated by our managed care entities under contracts with
Humana accounted for approximately 78% and 75% of our medical services revenue for Fiscal 2005 and
2004, respectively. Revenue from continuing operations generated by our managed care entities
under contracts with Vista accounted for 22% and 25% of our medical services revenue for Fiscal
2005 and 2004, respectively.
Expenses from Continuing Operations
Medical services expenses are comprised of medical claims expense and other direct costs
related to the provision of medical services to our patients. Because our full risk contracts with
HMOs provide that we are financially responsible for all medical services provided to our patients
under those contracts, our medical claims expense includes the costs of medical services provided
to patients under our full risk contracts by providers other than us. Other direct costs include
the salaries, taxes and benefits of our health professionals providing primary care services,
medical malpractice insurance costs, capitation payments to our IPA physicians and other costs
related to the provision of medical services to our patients.
Medical services expenses for Fiscal 2005 increased by $5.8 million, or 6.5%, to $93.8 million
from $88.0 million for Fiscal 2004. However, as a percentage of total revenue, medical services
expenses decreased to 83.5% for Fiscal 2005 as compared to 86.4% for Fiscal 2004. Medical claims
expense increased by $4.8 million, or 6.3%, to $81.1 million for Fiscal 2005 from $76.3 million for
Fiscal 2004 primarily as a result of higher medical costs and an increase in utilization of health
care services by our Medicare patients, partially offset by a decrease in claims expense of
approximately $1.7 million which resulted from the conversion of certain commercial members of an
HMO from a risk arrangement to a non-risk arrangement during Fiscal 2005. As a result of these
developments, during Fiscal 2005 our medical claims expense related to our Medicare patients
increased on a per patient per month basis by approximately 16.1%.
Notwithstanding the increase in the amount of our medical services expenses and claims expense
during Fiscal 2005, the increase in our medical services revenue more than offset the increase in
our medical services expenses and claims expense. As a result, our claims loss ratio (medical
claims expense as a percentage of medical services revenue) decreased to 72.9% in Fiscal 2005 from
75.5% in Fiscal 2004. However, in response to the Medicare Modernization Act, certain benefits
offered to Medicare patients were enhanced by the HMOs. We anticipate that these benefit changes
will result in an increase in our medical claims expense and may result in an increase in our
claims loss ratio in future periods. We cannot quantify what impact, if any, these developments
may have on our claims loss ratio (which fluctuates from period to period) or results of operations
in future periods.
Other direct costs increased by $0.9 million, or 8.4%, to $12.6 million for Fiscal 2005 from
$11.7 million for Fiscal 2004. As a percentage of total revenue, other direct costs decreased to
11.2% for Fiscal 2005 from 11.4% for Fiscal 2004. The increase in the
23
amount of other direct costs was primarily due to an increase in payroll expense and related
benefits for physicians and medical support personnel at our medical centers and an increase in
incentive plan accruals.
Administrative payroll and employee benefits expense increased by $1.3 million, or 33.6%, to
$5.1 million for Fiscal 2005 from $3.8 million for Fiscal 2004. As a percentage of total revenue,
administrative payroll and employee benefits expense increased to 4.6% for Fiscal 2005 from 3.8%
for Fiscal 2004. The increase in administrative payroll and employee benefits expense was due to
an increase in salaries related to the hiring of additional marketing and executive personnel and
an increase in incentive plan accruals.
General and administrative expenses increased by $1.2 million, or 21.3%, to $7.1 million for
Fiscal 2005 from $5.8 million for Fiscal 2004. As a percentage of total revenue, general and
administrative expenses increased to 6.3% for Fiscal 2005 from 5.7% for Fiscal 2004. The increase
in general and administrative expenses was primarily due to an increase in professional fees and
the settlement of two lawsuits during Fiscal 2004 which reduced our accrual for legal claims by
$0.8 million during that fiscal year.
The $3.0 million and $0.9 million gain on extinguishment of debt recognized during Fiscal 2005
and 2004, respectively, related to the $3.9 million contract modification note with Humana that was
cancelled in April 2003. Simultaneously with the note cancellation, we executed the Humana PGP
Agreement. The Humana PGP Agreement contained a provision for liquidated damages in the amount of
$4.0 million, which could be asserted by Humana under certain circumstances. To the extent that
Humana reduced the maximum amount of liquidated damages, we recognized gains from extinguishment of
debt in a corresponding amount. In Fiscal 2005 and Fiscal 2004, Humana notified us that the
maximum amount of liquidated damages had been reduced from $3.0 million to $0 and from $3.9 million
to $3.0 million, respectively. Accordingly, we recognized $3.0 million and $0.9 million of the
deferred gain on extinguishment of debt in Fiscal 2005 and 2004, respectively.
Income from Operations
Income from operations for Fiscal 2005 increased by $4.3 million, or 85.1%, to $9.3 million
from $5.0 million for Fiscal 2004. Income from operations for Fiscal 2005 increased to 8.3% of
total revenue as compared to 4.9% of total revenue for Fiscal 2004.
Medicare Settlement Related to Terminated Operations
During Fiscal 2004, we recorded other income of $2.2 million relating to the settlement of an
alleged Medicare obligation. The alleged obligation related to rehabilitation clinics that were
previously operated by one of our former subsidiaries and were sold in 1999. CMS had alleged that
Medicare overpayments were made relating to services rendered by these clinics and other related
clinics during a period in which the clinics were operated by entities other than us. We requested
that CMS reconsider the alleged liability, and in October 2003 we were notified that the liability
had been reduced from the originally asserted amount of $2.4 million to $0.2 million.
Loss from Discontinued Operations-Home Health Operations
Our home health operations contributed $3.1 million in revenue and generated an operating loss
of $1.7 million (which included charges in connection with the disposition of $0.5 million) during
Fiscal 2004.
Income from Discontinued Operations-Terminated IPAs
The terminated IPAs did not contribute any revenue but generated operating income of $73,000
during Fiscal 2004. Income generated by the terminated IPAs during Fiscal 2004 resulted from a
settlement with the HMO which eliminated all amounts due to and amounts due from the HMO incurred
prior to the termination of the contracts on January 1, 2003.
Taxes
We periodically perform an analysis of the realizability of our deferred tax assets based on
our assessment of current and expected operating results. As of June 30, 2005, we determined that
no valuation allowance for deferred tax assets was necessary and we decreased our valuation
allowance by $10.2 million for Fiscal 2005. This decision had the effect of increasing our Fiscal
2005 net income by approximately $7.2 million. Since this decision eliminated our entire valuation
allowance, it represents a one-time gain that will not contribute to our earnings in future
periods. No provision for income taxes was recorded in Fiscal 2004 due primarily to the
utilization of prior year net operating loss carryforwards. As a result of our utilization of
deferred tax assets during Fiscal 2004, we reduced the valuation allowance for our deferred tax
assets by $1.7 million as of June 30, 2004 to offset income tax liabilities that were generated
from current operations.
24
Net Income
Net income for Fiscal 2005 increased by $11.2 million, or 242%, to $15.9 million from $4.7
million for Fiscal 2004.
COMPARISON OF FISCAL YEAR ENDED JUNE 30, 2004 TO FISCAL YEAR ENDED JUNE 30, 2003
Revenue from Continuing Operations
Medical services revenue increased by $3.9 million, or 4.1%, to $101.1 million for Fiscal 2004
from $97.2 million for Fiscal 2003 primarily due to an increase in our Medicare revenue resulting
from the Medicare Modernization Act and the increased phase-in of the Medicare risk adjustment
program, both of which became effective in January 2004. During Fiscal 2004 revenue generated by
our Medicare full risk contracts increased approximately 8.1% on a per patient per month basis
which was partially offset by a decrease of approximately 2.2% in Medicare patients months.
Management fee revenue of $0.7 million during Fiscal 2004 related to revenue generated under
our limited risk and non-risk contracts under the Humana PGP Agreement. We executed the Humana PGP
Agreement in April 2003 and did not record any revenue under it during Fiscal 2003.
Revenue from continuing operations generated by our managed care entities under contracts with
Humana accounted for 75% and 73% of our medical services revenue for Fiscal 2004 and 2003,
respectively. Revenue from continuing operations generated by our managed care entities under
contracts with Vista accounted for 25% and 23% of our medical services revenue for Fiscal 2004 and
2003, respectively.
Expenses from Continuing Operations
Medical services expenses for Fiscal 2004 increased by $3.3 million, or 3.8%, to $88.0 million
from $84.7 million for Fiscal 2003. However, as a percentage of total revenue, medical services
expenses decreased to 86.4% for Fiscal 2004 as compared to 87.2% of total revenue for Fiscal 2003.
Medical claims expense increased by $2.3 million, or 3.1%, to $76.3 million for Fiscal 2004 from
$74.0 million for Fiscal 2003 primarily as a result of higher stop-loss insurance costs and an
increase in utilization of health care services during 2004.
Notwithstanding the increase in our medical services expenses and claims during Fiscal 2004,
the increase in medical services revenue more than offset the increase in our medical services
expenses and claims expenses. As a result, our claims loss ratio decreased to 75.5% in Fiscal 2004
from 76.2% in Fiscal 2003.
Other direct costs increased by $1.0 million, or 9.1%, to $11.7 million for Fiscal 2004 from
$10.7 million for Fiscal 2003. As a percentage of total revenue, other direct costs increased to
11.4% for Fiscal 2004 from 11.0% for Fiscal 2003. The increase in other direct costs was primarily
due to an increase in payroll expense for physicians and medical support personnel at our medical
centers and an increase in medical malpractice insurance costs.
Administrative payroll and employee benefits for Fiscal 2004 and 2003 remained relatively
constant at $3.8 million and $3.7 million, respectively, or 3.8% of total revenue for each year.
General and administrative expenses decreased by $0.5 million, or 6.9%, to $5.8 million for
Fiscal 2004 from $6.3 million for Fiscal 2003. As a percentage of total revenue, general and
administrative expenses decreased to 5.7% for Fiscal 2004 as compared to 6.4% for Fiscal 2003. The
decrease in general and administrative expenses was primarily due to the settlement of two lawsuits
in Fiscal 2004 as discussed above, which was partially offset by separation costs of $0.3 million
incurred in Fiscal 2004 in connection with the resignation of our former president.
The $0.9 million gain on extinguishment of debt recognized during Fiscal 2004 related to the
$3.9 million contract modification note with Humana that was cancelled in April 2003. In May 2004,
Humana notified us that the maximum amount of liquidated damages under the Humana PGP Agreement had
been reduced to $3.0 million. Accordingly, we recognized $0.9 million of the deferred gain on
extinguishment of debt during Fiscal 2004. No similar transaction occurred during Fiscal 2003.
Income from Operations
Income from operations for Fiscal 2004 increased by $2.5 million to $5.0 million, or 4.9% of
total revenue, from $2.5 million, or 2.6% of total revenue, for Fiscal 2003.
25
Medicare Settlement Related to Terminated Operations
During Fiscal 2004, we recorded other income of $2.2 million relating to the settlement of the
alleged Medicare obligation discussed above.
Loss from Discontinued Operations-Home Health Operations
Our home health operations contributed $3.1 million and $4.2 million in revenue and generated
operating losses of $1.7 million (which included charges in connection with the disposition of $0.5
million) and $1.8 million during Fiscal 2004 and 2003, respectively.
Income from Discontinued Operations-Terminated IPAs
The IPAs we terminated effective January 1, 2003 contributed $4.5 million in medical services
revenue and generated operating income of $351,000 during Fiscal 2003. The terminated IPAs did not
contribute any revenue but generated operating income of $73,000 during Fiscal 2004. Income
generated by the terminated IPAs during Fiscal 2004 resulted from a settlement with the HMO which
eliminated all amounts due to and amounts due from the HMO incurred prior to the termination of the
contracts on January 1, 2003.
Taxes
No provision for income taxes was recorded in Fiscal 2004 and 2003 due primarily to the
utilization of prior year net operating loss carryforwards. We periodically perform an analysis of
the realizability of our deferred tax assets based on our assessment of current and expected
operating results. As a result of our utilization of deferred tax assets during Fiscal 2004, we
reduced the valuation allowance for our deferred tax assets by $1.7 million as of June 30, 2004.
The valuation allowance reduction was due to the utilization of deferred tax assets during Fiscal
2004 to offset income tax liabilities that were generated from current operations.
Net Income
Net income for Fiscal 2004 increased by $4.6 million to $4.7 million from $0.1 million for
Fiscal 2003.
Liquidity and Capital Resources
At June 30, 2005, working capital was $6.9 million, an increase of $7.4 million from a working
capital deficit of $0.5 million at June 30, 2004. The increase in working capital for Fiscal 2005
was primarily due to income from continuing operations before income tax benefit of $8.7 million.
Cash and cash equivalents were $5.8 million at June 30, 2005 compared to $0.7 million at June 30,
2004.
Net cash of $7.9 million was provided by operating activities from continuing operations
during Fiscal 2005 compared to $2.3 million in Fiscal 2004 and $3.1 million in Fiscal 2003. The
increase of $5.6 million in cash provided by operating activities from continuing operations during
Fiscal 2005 was primarily due to an increase in income from operations of $4.3 million, an increase
in accrued expenses and other current liabilities of $1.5 million, and a decrease in the Medicare settlement
related to terminated operations of $2.2 million recognized in Fiscal 2004, which were partially
offset by an increase in extinguishment of debt of $2.2 million. The decrease of $0.8 million in
cash provided by operating activities during Fiscal 2004 was primarily due to an increase of $1.7
million in amounts due from HMOs, a decrease in accounts payable,
accrued expenses and other current liabilities of $0.6
million, income recognized of $2.2 million in connection with the Medicare settlement related to
terminated operations, and a gain of $0.9 million on the early extinguishment of debt, which taken
together, more than offset our $4.7 million increase in income from continuing operations.
Net cash of $0.8 million was used for investing activities from continuing operations in
Fiscal 2005 compared to $0.1 million in Fiscal 2004 and $0.1 million in Fiscal 2003. The increase
of $0.7 million in cash used for investing activities from continuing operations during Fiscal 2005
was primarily due to an increase in the purchase of equipment of $0.3 million and the purchase of a
$0.5 million certificate of deposit. The $0.5 million certificate of deposit is pledged as
collateral in support of a $0.5 million irrevocable standby letter of credit we are required to
maintain for the benefit of one of our HMO affiliates. The letter of credit will be maintained
throughout the term of the managed care agreement with that HMO and can be drawn upon by the HMO if
we are delinquent in making payments due to the HMO.
Net cash of $1.8 million was used in financing activities from continuing operations in Fiscal
2005 compared to net cash used
26
of $0.6 million in Fiscal 2004. The increase of $1.2 million in cash used in financing activities
from continuing operations in Fiscal 2005 was primarily due to the repurchase of common stock of
$2.3 million which was partially offset by an increase in proceeds of $1.0 million from the
promissory note payable to Humana discussed below. The decrease in cash used in financing
activities of $0.5 million in Fiscal 2004 was primarily due to an increase in proceeds of $3.5
million from the issuance of stock and $0.4 million from the exercise of stock options that were
partially offset by an increase of $1.1 million in repayments to Medicare and an increase of $2.3
million in payments of our $3.0 million credit facility.
On April 12, 2004, we called our convertible subordinated notes payable for redemption in
accordance with their terms, subject to the noteholders right to convert their notes prior to the
redemption date into shares of our common stock. The outstanding principal balance of the notes as
of March 31, 2004 was approximately $3.9 million. On May 12, 2004 all noteholders converted their
notes in accordance with these terms and received 3,922,539 shares of common stock, representing
the conversion and cancellation of the entire outstanding principal balance of the notes and the
unpaid accrued interest through the conversion date.
On April 22, 2004, we sold 2,333,333 shares of our common stock for $3.5 million to twelve
accredited investors in a private transaction. The proceeds were used to retire approximately $1.4
million of long-term debt bearing interest at rates ranging from 12.625% to 13.875%, to reduce the
balance outstanding under our credit facility by approximately $1.7 million and for general
corporate purposes. In connection with the transaction, an entity controlled by Dr. Frost, a
member of our Board of Directors and our principal shareholder, converted a convertible promissory
note having an outstanding principal balance and unpaid accrued interest of approximately $0.9
million into 819,313 shares of common stock in accordance with the terms of that note.
On December 30, 2004, we received cash of $1,040,000 from Humana in exchange for an unsecured,
non-interest bearing promissory note for an equal amount. The promissory note is payable in 12
monthly installments of $86,666, through December 1, 2005, but we can prepay the promissory note in
full or in part at any time without penalty or premium. As of June 30, 2005, we had made principal
payments amounting to $520,000, reducing the outstanding balance on the promissory note to
$520,000. Amounts due under the promissory note are subject to acceleration upon the happening of
customary events of default, including the failure to make payments of principal.
Effective March 30, 2005, we obtained an extension of the maturity date for our credit
facility until March 31, 2006. The terms and conditions of the credit facility remain
substantially unchanged after the extension of the maturity date, except that the terms of the
credit facility now require us to maintain a minimum cash and cash equivalent balance of $1.0
million. As a result of the extension of the maturity date of the credit facility, Dr. Frost is
now no longer required to personally guarantee our obligations under the credit facility. At June
30, 2005, we had no amounts outstanding under our credit facility.
In May 2005, our Board of Directors increased our previously announced program to repurchase
shares of our common stock to a total of 2,500,000 shares. Any such repurchases will be made from
time to time at the discretion of our management in the open market or in privately negotiated
transactions subject to market conditions and other factors. We anticipate that any such
repurchases of shares will be funded through cash from operations. As of September 1, 2005, we had
repurchased 957,467 shares of our common stock for approximately $2,453,000.
We believe that we will be able to fund our capital commitments, our anticipated operating
cash requirements for the foreseeable future and satisfy any remaining obligations from our working
capital, anticipated cash flows from operations, and our Credit Facility.
Off-Balance Sheet Arrangements
We had no off-balance sheet arrangements as of June 30, 2005, and have not entered into any
transactions involving unconsolidated, limited purpose entities or commodity contracts.
27
Contractual Obligations
The following is a summary of our long-term debt, capital lease obligations, and contractual
obligations as of June 30, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment due by Period |
|
|
Total |
|
Less than 1 Year |
|
1-2 Years |
|
3-5 Years |
Long-Term Debt Obligations |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Related Party Notes Payable,
including capitalized interest
(1) |
|
|
103,338 |
|
|
|
103,338 |
|
|
|
|
|
|
|
|
|
Capital Lease Obligations (2) |
|
|
118,425 |
|
|
|
76,404 |
|
|
|
42,021 |
|
|
|
|
|
Operating Lease Obligations (2) |
|
|
5,539,398 |
|
|
|
1,722,924 |
|
|
|
3,221,600 |
|
|
|
594,874 |
|
|
|
|
Total |
|
$ |
5,761,161 |
|
|
$ |
1,902,666 |
|
|
$ |
3,263,621 |
|
|
$ |
594,874 |
|
|
|
|
|
|
|
(1) |
|
The payments shown above for our Related Party Notes Payable include
interest that was capitalized in accordance with Statement of Financial
Accounting Standards No. 15, Accounting by Debtors and Creditors for Troubled
Debt Restructurings. See Note 8 to our Consolidated Financial Statements. |
|
(2) |
|
The payments shown above for Capital Lease Obligations and Operating
Lease Obligations reflect all payments due under the terms of the respective
leases. See Note 4 to our Consolidated Financial Statements to reconcile the
payments shown above to the capital lease obligation recorded in our
Consolidated Balance Sheet. |
Other factors that could affect our liquidity and cash flow are discussed elsewhere in this Annual Report.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
At June 30, 2005, we had only certificates of deposit and cash equivalents invested in high
grade, short-term securities, which are not typically subject to material market risk. We have
loans outstanding at fixed rates. For loans with fixed interest rates, a hypothetical 10% change
in interest rates would have no impact on our future earnings and cash flows related to these
instruments and would have an immaterial impact on the fair value of these instruments. Our Credit
Facility is interest rate sensitive, however, we had no amount outstanding under this facility at
June 30, 2005. We have no risk associated with foreign currency exchange rates or commodity prices.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Our consolidated financial statements and independent registered public accountants reports
thereon appear beginning on page F-2. See index to such consolidated financial statements and
reports on page F-1.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
None.
ITEM 9A. CONTROLS AND PROCEDURES
Our management has evaluated, with the participation of our Chief Executive Officer and Chief
Financial Officer, the effectiveness of our disclosure controls and procedures, as of June 30,
2005. We have restated our previously issued financial statements for the fiscal
year ended June 30, 2004 to give effect to the financial impact of a latent error in an automated
software system used to submit patient data to one of our HMO affiliates. During May 2005, we
corrected the software error in question, and we believe that this correction effectively
remediates any weakness that the software error may have caused in our disclosure controls and
procedures. Accordingly, we believe that our disclosure controls and procedures are now effective.
However, that conclusion should be considered in light of the various limitations described below
on the effectiveness of those controls and procedures, some of which pertain to most if not all
business enterprises, and some of which arise as a result of the nature of our business. Our
management, including our Chief Executive Officer and our Chief Financial Officer, does not expect
that our disclosure controls and procedures will prevent all errors and all improper conduct. A
control system, no matter how well conceived and operated, can provide only reasonable, not
absolute, assurance that the objectives of the control system are met. Further, the design of a
control system must reflect the fact that there are resource constraints, and the benefits of
controls must be considered relative to their costs. Because of the inherent limitations in all
control systems, no evaluation of controls can provide absolute assurance that all control issues
and instances of improper conduct, if any, have been detected. These inherent limitations include
the realities that judgments in decision-making can be faulty, and that breakdowns
28
can occur because of simple error or mistake. Additionally, controls can be circumvented by
the individual acts of some persons, by collusion of two or more people, or by management override
of the control. Further, the design of any system of controls also is based in part upon
assumptions about the likelihood of future events, and there can be no assurance that any design
will succeed in achieving its stated goals under all potential future conditions; over time,
controls may become inadequate because of changes in conditions, or the degree of compliance with
the policies or procedures may deteriorate. Because of the inherent limitations in a
cost-effective control system, misstatements due to error or fraud may occur and not be detected.
In addition, we depend on our HMO affiliates for certain financial and other information that we
receive concerning the medical services revenue and expenses that we earn and incur. Because our
HMO affiliates generate that information for us we have less control over the manner in which that
information is generated. There were no changes in our internal controls or other factors during
the fourth quarter of our fiscal year, nor were there any corrective actions required with regard
to significant deficiencies and material weaknesses, other than the remediation of the software
error described above.
Provided with this Annual Report are certifications of our Chief Executive Officer and our
Chief Financial Officer. We are required to provide those certifications by Section 302 of the
Sarbanes-Oxley Act of 2002 and the Securities and Exchange Commissions implementing regulations.
Item 9A of this Annual Report is the information concerning the evaluation referred to in those
certifications, and you should read this information in conjunction with those certifications for a
more complete understanding of the topics presented.
ITEM 9B. OTHER INFORMATION
Not applicable.
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The information required by Item 10 is incorporated by reference to our Proxy Statement for
our 2005 Annual Meeting of Shareholders, which will be filed with the Securities and Exchange
Commission by October 28, 2005.
ITEM 11. EXECUTIVE COMPENSATION AND OTHER INFORMATION
The information required by Item 11 is incorporated by reference to our Proxy Statement for
our 2005 Annual Meeting of Shareholders, which will be filed with the Securities and Exchange
Commission by October 28, 2005.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The information required by Item 12 is incorporated by reference to our Proxy Statement for
our 2005 Annual Meeting of Shareholders, which will be filed with the Securities and Exchange
Commission by October 28, 2005.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
The information required by Item 13 is incorporated by reference to our Proxy Statement for
our 2005 Annual Meeting of Shareholders, which will be filed with the Securities and Exchange
Commission by October 28, 2005.
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by Item 14 is incorporated by reference to our Proxy Statement for
our 2005 Annual Meeting of Shareholders, which will be filed with the Securities and Exchange
Commission by October 28, 2005.
PART IV
ITEM
15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K
(a)(1) Financial Statements
Reference is made to the Index set forth on Page F-1 of this Annual Report on Form 10-K/A.
(a)(2) Financial Statement Schedules
29
All schedules have been omitted because they are inapplicable or the information is
provided in the consolidated financial statements, including the notes hereto.
(a)(3) Exhibits
|
|
|
3.1
|
|
Restated Articles of Incorporation, as amended (1) |
|
|
|
3.2
|
|
Restated Bylaws (2) |
|
|
|
4.1
|
|
Form of certificate evidencing shares of Common Stock (1) |
|
|
|
4.2
|
|
Registration Rights Agreement, dated as of October 30, 1997, by and
between Continucare Corporation and Loewenbaum & Company
Incorporated (3) |
|
|
|
4.3
|
|
Continucare Corporation Amended and
Restated 1995 Stock Option Plan** (4) |
|
|
|
4.4
|
|
Amended and Restated 2000 Stock
Option Plan ** (5) |
|
|
|
4.5
|
|
Convertible Subordinated Promissory
Note (6) |
|
|
|
4.6
|
|
Form of Convertible Promissory
Note, dated June 30, 2001 (7) |
|
|
|
4.7
|
|
Amendment to Convertible Promissory Note, dated March 31, 2003, between
Continucare Corporation and Frost Nevada Limited Partnership (7) |
|
|
|
4.8
|
|
Form of Amendment to Convertible
Promissory Note, dated March 31, 2003 (7) |
|
|
|
10.1
|
|
Form of Stock Option Agreement** (8) |
|
|
|
10.2
|
|
Physician Practice Management Participation Agreement between Continucare
Medical Management, Inc., and Humana Medical Plan, Inc. entered into as of
the 1st
day of August, 1998 (9) |
|
|
|
10.3
|
|
Amended and Restated Primary Care Provider Services dated November 12,
2004, by and between Vista Healthplan of South Florida, Inc., Vista
Insurance Plan, Inc. and Continucare Medical Management, Inc. (10) |
|
|
|
10.4
|
|
Airport Corporate Center office lease dated June 3, 2004, by and between
Miami RPFIV Airport Corporate Center Associates Limited Liability Company
and Continucare Corporation(11) |
|
|
|
10.5
|
|
Amendment No. 1 to Primary Care Provider Services Agreement dated as of
July 1, 2004 by and among Vista Healthplan of South Florida,
Inc. (10) |
|
|
|
10.6
|
|
Agreement, dated March 31, 2003, between the Company and Pecks Management
Partners, Ltd. (7) |
|
|
|
10.7
|
|
Agreement, dated March 31, 2003, between Continucare Corporation and
Carret & Company (7) |
|
|
|
10.8
|
|
WCMA Loan and Security Agreement dated March 9, 2000 between Merrill Lynch
Business Financial Services, Inc. and Continucare Corporation (12) |
|
|
|
10.9
|
|
Letter Agreement dated March 18, 2005 between Merrill Lynch Business
Financial Services, Inc. and Continucare Corporation (13) |
|
|
|
10.10
|
|
Consulting Agreement dated May 4, 2005 between Patrick Healy and
Continucare Corporation (13) |
|
|
|
10.11
|
|
Form of Promissory Note dated
December 29, 2004 (14) |
|
|
|
21.1
|
|
Subsidiaries of the Company (11) |
|
|
|
23.1
|
|
Consent of Independent Registered Public Accounting Firm * |
|
|
|
31.1
|
|
Section 302 Certification of Chief Executive Officer * |
|
|
|
31.2
|
|
Section 302 Certification of Chief Financial Officer * |
|
|
|
32.1
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 * |
|
|
|
32.2
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 * |
Documents incorporated by reference to the indicated exhibit to the following filings by the
Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934.
30
|
|
|
|
(1 |
) |
|
Post Effective Amendment No. 1 to the Registration Statement on SB-2
on Form S-3 Registration Statement filed on October 29, 1996. |
|
|
|
|
(2 |
) |
|
Registration Statement on Form SB-2
filed on January 17, 1995. |
|
|
|
|
(3 |
) |
|
Form 8-K dated October 30, 1997 and filed with the Commission on
November 13, 1997. |
|
|
|
|
(4 |
) |
|
Schedule 14A dated December 26, 1997 and filed with the Commission on
December 30, 1997. |
|
|
|
|
(5 |
) |
|
Schedule 14A dated July 28, 2004, filed July 28, 2004. |
|
|
|
|
(6 |
) |
|
Form 8-K dated August 3, 2001, filed August 15, 2001. |
|
|
|
|
(7 |
) |
|
Form 10-Q for the quarterly period ended March 31, 2003. |
|
|
|
|
(8 |
) |
|
Form 10-Q for the quarterly
period ended September 30, 2004. |
|
|
|
|
(9 |
) |
|
Form 10-K for the fiscal year ended June 30, 2000. |
|
|
|
|
(10 |
) |
|
Form 10-Q for the quarterly
period ended December 31, 2004. |
|
|
|
|
(11 |
) |
|
Form 10-K for the fiscal year ended June 30, 2004. |
|
|
|
|
(12 |
) |
|
Form 10-Q for the quarterly
period ended March 31, 2000. |
|
|
|
|
(13 |
) |
|
Form 10-Q for the quarterly period ended March 31, 2005. |
|
|
|
|
(14 |
) |
|
Form 8-K dated
December 30, 2004, filed January 5, 2005. |
|
|
|
* |
|
Filed herewith |
|
** |
|
Management contract or compensatory plan or arrangement |
31
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
|
|
|
|
CONTINUCARE CORPORATION |
|
|
|
|
|
|
|
By:
|
|
/s/ Richard C. Pfenniger, Jr. |
|
|
|
|
|
|
|
|
|
RICHARD C. PFENNIGER, JR. |
|
|
|
|
Chairman of the Board, Chief Executive Officer and President |
Dated:
September 19, 2005
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the registrant and in the
capacities and on the dates indicated.
|
|
|
|
|
SIGNATURE |
|
TITLE |
|
DATE |
|
|
|
|
|
/s/ Richard C. Pfenniger, Jr.
Richard C. Pfenniger, Jr.
|
|
Chairman of the Board, Chief Executive
Officer, President and Director
(Principal Executive Officer)
|
|
September 19, 2005 |
|
|
|
|
|
/s/ Fernando L. Fernandez
Fernando L. Fernandez
|
|
Senior Vice President Finance, Chief
Financial Officer, Treasurer and Secretary
(Principal Financial and Accounting Officer)
|
|
September 19, 2005 |
|
|
|
|
|
/s/ Robert J. Cresci
Robert J. Cresci
|
|
Director
|
|
September 19, 2005 |
|
|
|
|
|
/s/ Phillip Frost, M.D.
Phillip Frost, M.D.
|
|
Director
|
|
September 19, 2005 |
|
|
|
|
|
/s/ Neil Flanzraich
Neil Flanzraich
|
|
Director
|
|
September 19, 2005 |
|
|
|
|
|
/s/ Jacob Nudel, M.D.
Jacob Nudel, M.D.
|
|
Director
|
|
September 19, 2005 |
|
|
|
|
|
/s/ A. Marvin Strait
A. Marvin Strait
|
|
Director
|
|
September 19, 2005 |
32
INDEX TO FINANCIAL STATEMENTS
|
|
|
|
|
|
|
PAGE |
|
|
|
|
F-2 |
|
|
|
|
F-3 |
|
|
|
|
F-4 |
|
|
|
|
F-5 |
|
|
|
|
F-6 |
|
|
|
|
F-8 |
|
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders of
Continucare Corporation
We have audited the accompanying consolidated balance sheets of Continucare Corporation as of June
30, 2005 and 2004, and the related consolidated statements of income, shareholders equity and cash
flows for each of the three years in the period ended June 30, 2005. These financial statements are
the responsibility of the Companys management. Our responsibility is to express an opinion on
these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. We
were not engaged to perform an audit of the Companys internal control over financial reporting.
Our audit included consideration of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Companys internal control over financial
reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by management, and evaluating the overall
financial statement presentation. We believe that our audits provide a reasonable basis for our
opinion.
In our opinion, the financial statements referred to above present fairly, in all material
respects, the consolidated financial position of Continucare Corporation at June 30, 2005 and 2004,
and the consolidated results of its operations and its cash flows for each of the three years in
the period ended June 30, 2005, in conformity with U.S. generally accepted accounting principles.
|
|
|
|
|
/s/ ERNST & YOUNG LLP |
|
|
CERTIFIED PUBLIC ACCOUNTANTS |
|
|
|
West Palm Beach, Florida |
|
|
September
14, 2005 |
|
|
F-2
CONTINUCARE CORPORATION
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
|
2005 |
|
|
2004 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
5,780,544 |
|
|
$ |
720,360 |
|
Other receivables, net |
|
|
144,973 |
|
|
|
423,215 |
|
Due from HMOs, net of a liability for incurred but not reported medical claims
expense of approximately $11,700,000 and $11,450,000 at June 30, 2005 and 2004,
respectively |
|
|
3,485,530 |
|
|
|
2,701,878 |
|
Prepaid expenses and other current assets |
|
|
719,577 |
|
|
|
992,321 |
|
Deferred tax assets, net |
|
|
585,571 |
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
10,716,195 |
|
|
|
4,837,774 |
|
Certificates of deposit, restricted |
|
|
530,350 |
|
|
|
30,000 |
|
Equipment, furniture and leasehold improvements, net |
|
|
670,665 |
|
|
|
492,054 |
|
Goodwill, net of accumulated amortization of approximately $7,608,000 |
|
|
14,342,510 |
|
|
|
14,342,510 |
|
Managed care contracts, net of accumulated amortization of approximately $2,422,000
and $2,069,000 at June 30, 2005 and 2004, respectively |
|
|
1,090,046 |
|
|
|
1,442,858 |
|
Deferred financing costs, net of accumulated amortization of $222,500 at June 30, 2004 |
|
|
|
|
|
|
662,502 |
|
Deferred tax assets, net |
|
|
6,721,353 |
|
|
|
|
|
Other assets, net |
|
|
66,816 |
|
|
|
100,483 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
34,137,935 |
|
|
$ |
21,908,181 |
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
660,139 |
|
|
$ |
504,151 |
|
Accrued expenses and other current liabilities |
|
|
2,620,802 |
|
|
|
1,794,019 |
|
Note payable |
|
|
520,000 |
|
|
|
|
|
Deferred revenue |
|
|
|
|
|
|
3,000,000 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
3,800,941 |
|
|
|
5,298,170 |
|
Capital lease obligations, less current portion |
|
|
38,361 |
|
|
|
101,177 |
|
Related party notes payable, less current portion |
|
|
|
|
|
|
117,717 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
3,839,302 |
|
|
|
5,517,064 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Shareholders equity: |
|
|
|
|
|
|
|
|
Common stock, $0.0001 par value: 100,000,000 shares authorized; 52,591,895 shares
issued and 49,595,702 shares outstanding at June 30, 2005 and 53,296,379 shares
issued and 50,300,186 shares outstanding at June 30, 2004 |
|
|
4,960 |
|
|
|
5,031 |
|
Additional paid-in capital |
|
|
67,924,068 |
|
|
|
69,907,973 |
|
Accumulated deficit |
|
|
(32,205,694 |
) |
|
|
(48,097,186 |
) |
Treasury stock, 2,996,193 shares at June 30, 2005 and 2004 |
|
|
(5,424,701 |
) |
|
|
(5,424,701 |
) |
|
|
|
|
|
|
|
Total shareholders equity |
|
|
30,298,633 |
|
|
|
16,391,117 |
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity |
|
$ |
34,137,935 |
|
|
$ |
21,908,181 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
F-3
CONTINUCARE CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended June 30, |
|
|
|
2005 |
|
|
2004 |
|
|
2003 |
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
Medical services revenue, net |
|
$ |
111,316,174 |
|
|
$ |
101,123,346 |
|
|
$ |
97,164,834 |
|
Management fee revenue and other income |
|
|
914,939 |
|
|
|
700,756 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
|
112,231,113 |
|
|
|
101,824,102 |
|
|
|
97,164,834 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Medical services: |
|
|
|
|
|
|
|
|
|
|
|
|
Medical claims |
|
|
81,104,665 |
|
|
|
76,333,580 |
|
|
|
74,046,265 |
|
Other direct costs |
|
|
12,648,297 |
|
|
|
11,665,894 |
|
|
|
10,696,997 |
|
|
|
|
|
|
|
|
|
|
|
Total medical services |
|
|
93,752,962 |
|
|
|
87,999,474 |
|
|
|
84,743,262 |
|
|
|
|
|
|
|
|
|
|
|
Administrative payroll and employee benefits |
|
|
5,107,672 |
|
|
|
3,822,949 |
|
|
|
3,681,446 |
|
General and administrative |
|
|
7,059,602 |
|
|
|
5,821,871 |
|
|
|
6,252,347 |
|
Gain on extinguishment of debt |
|
|
(3,000,000 |
) |
|
|
(850,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
102,920,236 |
|
|
|
96,794,294 |
|
|
|
94,677,055 |
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
9,310,877 |
|
|
|
5,029,808 |
|
|
|
2,487,779 |
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
108,000 |
|
|
|
4,793 |
|
|
|
6,568 |
|
Interest expense |
|
|
(702,946 |
) |
|
|
(1,006,082 |
) |
|
|
(956,327 |
) |
Medicare settlement related to terminated operations |
|
|
|
|
|
|
2,218,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income tax benefit |
|
|
8,715,931 |
|
|
|
6,246,797 |
|
|
|
1,538,020 |
|
Income tax benefit |
|
|
7,175,561 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
15,891,492 |
|
|
|
6,246,797 |
|
|
|
1,538,020 |
|
Income (loss) from discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
Home health operations |
|
|
|
|
|
|
(1,666,934 |
) |
|
|
(1,830,118 |
) |
Terminated IPAs |
|
|
|
|
|
|
73,091 |
|
|
|
350,696 |
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations |
|
|
|
|
|
|
(1,593,843 |
) |
|
|
(1,479,422 |
) |
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
15,891,492 |
|
|
$ |
4,652,954 |
|
|
$ |
58,598 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
.32 |
|
|
$ |
.14 |
|
|
$ |
.04 |
|
Loss from discontinued operations |
|
|
|
|
|
|
(.03 |
) |
|
|
(.04 |
) |
|
|
|
|
|
|
|
|
|
|
Net income per common share |
|
$ |
.32 |
|
|
$ |
.11 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income (loss) per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
.31 |
|
|
$ |
.12 |
|
|
$ |
.04 |
|
Loss from discontinued operations |
|
|
|
|
|
|
(.03 |
) |
|
|
(.04 |
) |
|
|
|
|
|
|
|
|
|
|
Net income per common share |
|
$ |
.31 |
|
|
$ |
.09 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
50,231,870 |
|
|
|
43,763,835 |
|
|
|
40,776,903 |
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
52,006,064 |
|
|
|
49,232,716 |
|
|
|
40,776,903 |
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
F-4
CONTINUCARE CORPORATION
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
|
|
|
|
|
Total |
|
|
|
Common Stock |
|
|
Paid-In |
|
|
Accumulated |
|
|
Treasury |
|
|
Shareholders |
|
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Deficit |
|
|
Stock |
|
|
Equity |
|
|
|
|
Balance at June 30,
2002 |
|
|
39,634,601 |
|
|
|
$3,964 |
|
|
$ |
59,511,614 |
|
|
|
$(52,808,738 |
) |
|
$ |
(5,424,701 |
) |
|
|
$1,282,139 |
|
Issuance of stock
for director
compensation |
|
|
900,000 |
|
|
|
90 |
|
|
|
122,910 |
|
|
|
|
|
|
|
|
|
|
|
123,000 |
|
Issuance of stock
to guarantor of
credit facility |
|
|
1,500,000 |
|
|
|
150 |
|
|
|
524,850 |
|
|
|
|
|
|
|
|
|
|
|
525,000 |
|
Issuance of stock
as consideration
for extension of
note repayment
terms |
|
|
344,400 |
|
|
|
35 |
|
|
|
120,506 |
|
|
|
|
|
|
|
|
|
|
|
120,541 |
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
58,598 |
|
|
|
|
|
|
|
58,598 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 30,
2003 |
|
|
42,379,001 |
|
|
|
4,239 |
|
|
|
60,279,880 |
|
|
|
(52,750,140 |
) |
|
|
(5,424,701 |
) |
|
|
2,109,278 |
|
Issuance of stock
to guarantor of
credit facility |
|
|
300,000 |
|
|
|
30 |
|
|
|
869,970 |
|
|
|
|
|
|
|
|
|
|
|
870,000 |
|
Issuance of stock
in private
placement
transaction |
|
|
2,333,333 |
|
|
|
233 |
|
|
|
3,464,376 |
|
|
|
|
|
|
|
|
|
|
|
3,464,609 |
|
Issuance of stock
upon exercise of
stock options |
|
|
546,000 |
|
|
|
55 |
|
|
|
351,315 |
|
|
|
|
|
|
|
|
|
|
|
351,370 |
|
Issuance of stock
upon conversion of
related party note
payable |
|
|
819,313 |
|
|
|
82 |
|
|
|
899,383 |
|
|
|
|
|
|
|
|
|
|
|
899,465 |
|
Issuance of stock
upon conversion of
subordinated notes
payable |
|
|
3,922,539 |
|
|
|
392 |
|
|
|
4,043,049 |
|
|
|
|
|
|
|
|
|
|
|
4,043,441 |
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,652,954 |
|
|
|
|
|
|
|
4,652,954 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 30,
2004 |
|
|
50,300,186 |
|
|
|
5,031 |
|
|
|
69,907,973 |
|
|
|
(48,097,186 |
) |
|
|
(5,424,701 |
) |
|
|
16,391,117 |
|
Recognition of
compensation
expense related to
issuance of stock
options |
|
|
|
|
|
|
|
|
|
|
264,802 |
|
|
|
|
|
|
|
|
|
|
|
264,802 |
|
Issuance of stock
upon exercise of
stock options |
|
|
156,666 |
|
|
|
16 |
|
|
|
91,683 |
|
|
|
|
|
|
|
|
|
|
|
91,699 |
|
Fees related to
private placement
transactions |
|
|
|
|
|
|
|
|
|
|
(98,244 |
) |
|
|
|
|
|
|
|
|
|
|
(98,244 |
) |
Issuance of stock
upon conversion of
related party note
payable |
|
|
14,550 |
|
|
|
1 |
|
|
|
14,549 |
|
|
|
|
|
|
|
|
|
|
|
14,550 |
|
Repurchase of
common stock |
|
|
(875,700 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,256,783 |
|
|
|
2,256,783 |
|
Retirement of
treasury stock |
|
|
|
|
|
|
(88 |
) |
|
|
(2,256,695 |
) |
|
|
|
|
|
|
(2,256,783 |
) |
|
|
(4,513,566 |
) |
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,891,492 |
|
|
|
|
|
|
|
15,891,492 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at June 30,
2005 |
|
|
49,595,702 |
|
|
|
$4,960 |
|
|
$ |
67,924,068 |
|
|
$ |
(32,205,694 |
) |
|
$ |
(5,424,701 |
) |
|
|
$30,298,633 |
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
F-5
CONTINUCARE CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended June 30, |
|
|
|
2005 |
|
|
2004 |
|
|
2003 |
|
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
15,891,492 |
|
|
$ |
4,652,954 |
|
|
$ |
58,598 |
|
Loss from discontinued operations |
|
|
|
|
|
|
1,593,843 |
|
|
|
1,479,422 |
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
15,891,492 |
|
|
|
6,246,797 |
|
|
|
1,538,020 |
|
|
|
|
|
|
|
|
|
|
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization, including amortization of
deferred
financing costs |
|
|
1,258,289 |
|
|
|
1,201,675 |
|
|
|
1,162,034 |
|
Provision for bad debts |
|
|
15,787 |
|
|
|
104,296 |
|
|
|
44,333 |
|
Recognition of compensation expense related to issuance
of stock options |
|
|
264,802 |
|
|
|
|
|
|
|
|
|
Medicare settlement related to terminated operations |
|
|
|
|
|
|
(2,218,278 |
) |
|
|
|
|
Loss on disposal of property and equipment and release
from asset related liabilities |
|
|
|
|
|
|
|
|
|
|
500 |
|
Director compensation paid through the issuance of
restricted common stock |
|
|
|
|
|
|
|
|
|
|
123,000 |
|
Gain on extinguishment of debt |
|
|
(3,000,000 |
) |
|
|
(850,000 |
) |
|
|
|
|
Deferred tax benefit |
|
|
(7,306,924 |
) |
|
|
|
|
|
|
|
|
Changes in operating assets and liabilities,
excluding the effect of disposals: |
|
|
|
|
|
|
|
|
|
|
|
|
Other receivables |
|
|
262,455 |
|
|
|
(12,450 |
) |
|
|
423,462 |
|
Due from HMOs, net |
|
|
(783,652 |
) |
|
|
(1,287,409 |
) |
|
|
384,182 |
|
Prepaid expenses and other current assets |
|
|
171,230 |
|
|
|
(105,724 |
) |
|
|
(297,231 |
) |
Other assets |
|
|
33,667 |
|
|
|
3,763 |
|
|
|
(29,629 |
) |
Accounts payable |
|
|
155,988 |
|
|
|
(179,337 |
) |
|
|
3,045 |
|
Accrued expenses and other current liabilities |
|
|
894,710 |
|
|
|
(608,629 |
) |
|
|
(214,011 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash provided by continuing operations |
|
|
7,857,844 |
|
|
|
2,294,704 |
|
|
|
3,137,705 |
|
Net cash used in discontinued operations |
|
|
(151,399 |
) |
|
|
(998,872 |
) |
|
|
(1,933,360 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
7,706,445 |
|
|
|
1,295,832 |
|
|
|
1,204,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from disposal of property and equipment |
|
|
|
|
|
|
|
|
|
|
500 |
|
Purchase of certificate of deposit |
|
|
(500,000 |
) |
|
|
(30,000 |
) |
|
|
(70,000 |
) |
Proceeds from maturity of certificates of deposit |
|
|
101,165 |
|
|
|
29,743 |
|
|
|
99,555 |
|
Purchase of property and equipment |
|
|
(421,586 |
) |
|
|
(144,585 |
) |
|
|
(170,273 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash used in continuing operations |
|
|
(820,421 |
) |
|
|
(144,842 |
) |
|
|
(140,218 |
) |
Net cash (used in) provided by discontinued operations |
|
|
|
|
|
|
(938 |
) |
|
|
15,751 |
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
(820,421 |
) |
|
|
(145,780 |
) |
|
|
(124,467 |
) |
Continued on next page.
F-6
CONTINUCARE CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended June 30, |
|
|
|
2005 |
|
|
2004 |
|
|
2003 |
|
CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from note payable |
|
|
1,040,000 |
|
|
|
|
|
|
|
|
|
Payments on note payable |
|
|
(520,000 |
) |
|
|
|
|
|
|
|
|
Proceeds from issuance of stock in
private placement transaction |
|
|
|
|
|
|
3,464,609 |
|
|
|
|
|
Payment of fees related to private
placement transactions |
|
|
(98,244 |
) |
|
|
|
|
|
|
|
|
Payments on convertible subordinated notes |
|
|
|
|
|
|
(233,716 |
) |
|
|
(273,896 |
) |
Payments on related party notes |
|
|
(7,882 |
) |
|
|
(35,953 |
) |
|
|
(63,853 |
) |
Principal repayments under capital lease
obligations |
|
|
(74,630 |
) |
|
|
(76,000 |
) |
|
|
(112,256 |
) |
Payment of deferred financing costs |
|
|
|
|
|
|
(15,000 |
) |
|
|
(15,000 |
) |
Proceeds from exercise of stock options |
|
|
91,699 |
|
|
|
351,370 |
|
|
|
|
|
Repurchase of common stock |
|
|
(2,256,783 |
) |
|
|
|
|
|
|
|
|
Payments on credit facility |
|
|
|
|
|
|
(2,315,000 |
) |
|
|
|
|
Advances from HMOs |
|
|
|
|
|
|
|
|
|
|
75,000 |
|
Payments on advances from HMOs |
|
|
|
|
|
|
|
|
|
|
(75,000 |
) |
Third party assumption of capital lease
obligation |
|
|
|
|
|
|
|
|
|
|
(1,789 |
) |
Repayments to Medicare per agreement |
|
|
|
|
|
|
(1,730,745 |
) |
|
|
(632,751 |
) |
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities |
|
|
(1,825,840 |
) |
|
|
(590,435 |
) |
|
|
(1,099,545 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents |
|
|
5,060,184 |
|
|
|
559,617 |
|
|
|
(19,667 |
) |
Cash and cash equivalents at beginning of fiscal year |
|
|
720,360 |
|
|
|
160,743 |
|
|
|
180,410 |
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of fiscal year |
|
$ |
5,780,544 |
|
|
$ |
720,360 |
|
|
$ |
160,743 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND
FINANCING TRANSACTIONS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement of treasury stock |
|
$ |
2,256,783 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued for deferred financing costs |
|
$ |
|
|
|
$ |
870,000 |
|
|
$ |
645,541 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued upon conversion of subordinated notes
payable |
|
$ |
|
|
|
$ |
4,043,441 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock issued upon conversion of related party notes
payable |
|
$ |
14,550 |
|
|
$ |
899,465 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note payable issued for refunds due to Medicare for
overpayments |
|
$ |
|
|
|
$ |
|
|
|
$ |
694,800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note payable canceled due to settlement of cost
report reopening |
|
$ |
|
|
|
$ |
|
|
|
$ |
222,574 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of furniture and fixtures with proceeds of
capital lease obligations |
|
$ |
|
|
|
$ |
61,820 |
|
|
$ |
167,258 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for interest |
|
$ |
40,229 |
|
|
$ |
563,750 |
|
|
$ |
325,337 |
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
F-7
CONTINUCARE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1
General
Continucare Corporation (Continucare or the Company), is a mixed model provider of primary care
physician services on an outpatient basis in Florida. The Company provides medical services to
patients through employee physicians, advanced registered nurse practitioners and physicians
assistants. Additionally, the Company provides practice management services to independent
physician affiliates (IPAs). Substantially all of the Companys net medical services revenues
are derived from managed care agreements with two health maintenance organizations, Humana Medical
Plans, Inc. (Humana) and Vista Healthplan of South Florida, Inc. and its affiliated companies
(Vista) (collectively, the HMOs). The Company was incorporated in 1996 as the successor to a
Florida corporation formed earlier in 1996.
Business
In an effort to streamline operations and stem operating losses, effective January 1, 2003, the
Company terminated the Medicare and Medicaid lines of business for all of the IPA physician
contracts associated with one HMO, which consisted of 29 physicians at the time of the termination.
Additionally, in December 2003, the Company implemented a plan to dispose of its home health
operations. The home health disposition occurred in three separate transactions and was concluded
on February 7, 2004. As a result of these transactions, the operations of the terminated IPAs and
the home health operations are shown as discontinued operations (see Note 3).
During the year ended June 30, 2005, the Companys claims loss ratio (medical claims expense
expressed as a percentage of medical services revenue) improved as compared to Fiscal 2004 due
primarily to an increase in revenue from higher per member premiums for Medicare members resulting
from the Medicare Prescription Drug Improvement and Modernization Act of 2003 (the Medicare
Modernization Act) and the increased phase-in of the Medicare risk adjustment program. In
response to the Medicare Modernization Act, the HMOs enhanced benefits offered to Medicare members.
The Company anticipates that these benefit changes will result in an increase in medical claims
expense and may result in an increase in the claims loss ratio in future periods. Increases in the
claims loss ratio could reduce the Companys profitability and cash flows in future periods. The
Company cannot predict what impact, if any, these developments may have on its results of
operations.
F-8
NOTE 2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
A summary of significant accounting policies followed by the Company is as follows:
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and its wholly-owned
subsidiaries. All significant intercompany transactions and balances have been eliminated in
consolidation.
Accounting Estimates
The preparation of consolidated financial statements in conformity with accounting principles
generally accepted in the United States (generally accepted accounting principles) requires
management to make estimates and assumptions that affect the reported amounts of assets,
liabilities, revenues, and expenses. Because of the inherent uncertainties of this process, actual
results could differ from those estimates. Such estimates include the recognition of revenue, the
recoverability of intangible assets, the collectibility of receivables, and the accrual for
incurred but not reported (IBNR) claims.
Fair Value of Financial Instruments
The Companys financial instruments consist mainly of cash and cash equivalents, certificates of
deposit, accounts receivable, accounts payable, related party notes payable, notes payable, and
capital lease obligations. The carrying amounts of the Companys cash and cash equivalents,
certificates of deposit, accounts receivable, accounts payable and notes payable approximate fair
value due to the short-term nature of these instruments. At June 30, 2005 and 2004, the fair value
of the related party notes payable was $253,000 and $241,000, respectively, based on the market
value of the Companys common stock. At June 30, 2005 and 2004, the carrying value of the
Companys capital lease obligations approximate fair value based on the terms of the obligations.
The Company has imputed interest on non-interest bearing debt using an incremental borrowing rate
of 8%.
Cash and Cash Equivalents
The Company defines cash and cash equivalents as those highly-liquid investments purchased with an
original maturity of three months or less.
Certificates of Deposit
Certificates of deposit have original maturities of greater than three months and are pledged as
collateral in support of various stand-by letters of credit issued as required under the managed
care agreement with one of the Companys HMO affiliates and as security for various leases.
F-9
Due from HMOs
The HMOs pay medical claims and other costs on the Companys behalf. Based on the terms of the
contracts with the HMOs, the Company receives a net payment from the HMOs that is calculated by
offsetting revenue earned with medical claims expense, calculated as claims paid on the Companys
behalf plus the HMOs estimate of claims incurred but not reported. Therefore, the amounts due
from HMOs are presented in the balance sheet net of the estimated amounts for incurred but not
reported medical claims.
Equipment, Furniture and Leasehold Improvements
Equipment, furniture and leasehold improvements are stated at cost. Depreciation is computed using
the straight-line method over the estimated useful lives of the related assets, which range from
three to five years. Leasehold improvements are amortized over the underlying assets useful lives
or the term of the lease, whichever is shorter. Repairs and maintenance costs are expensed as
incurred. Improvements and replacements are capitalized.
Goodwill and Other Intangible Assets
Effective July 1, 2001, the Company adopted Statement of Financial Accounting Standards (SFAS)
No. 142, Goodwill and Other Intangible Assets (SFAS No. 142). Under SFAS No. 142, goodwill and
intangible assets with indefinite useful lives are reviewed annually for impairment, or more
frequently if certain indicators arise. Intangible assets with definite useful lives are amortized
over their respective estimated useful lives to their estimated residual values, and also reviewed
for impairment annually, or more frequently if certain indicators arise, in accordance with SFAS
No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets (SFAS No. 144).
Indicators of a permanent impairment include, among other things, significant adverse changes in
legal factors or the business climate, loss of a key HMO contract, an adverse action by a
regulator, unanticipated competition, loss of key personnel or allocation of goodwill to a portion
of a business that is to be sold.
As the Company operates in a single segment of business, the Company has determined that it has a
single reporting unit and performs the impairment test for goodwill on an enterprise level. In
performing the impairment test, the Company compares the current market value of all of its
outstanding common stock to the current carrying value of the Companys total net assets, including
goodwill and intangible assets. Depending on the aggregate market value of the Companys
outstanding common stock at the time that an impairment test is required, there is a risk that a
portion of the intangible assets would be considered impaired and must be written-off during that
period. The Company performs the annual impairment test as of May 1st of each year.
Should it later be determined that an indicator of impairment has occurred, the Company would be
required to perform an additional impairment test. No impairment charges were required at June 30,
2005, 2004 or 2003.
The managed care contracts relate to the value of certain amendments to a managed care agreement
entered into with one of the Companys HMOs. The amendments, among other things, extended the term
of the original agreement with the HMO from six to ten years and modified for the Companys benefit
the value of the Medicare premium received by the Company. In consideration of these amendments,
the Company gave the HMO a $3.9 million promissory note (see Deferred Revenue section below). The
managed care contracts are subject to amortization and are being amortized over a weighted-average
amortization period of 9.6 years. Total amortization expense for intangible assets subject to
amortization was approximately $353,000, $353,000 and $360,000 during Fiscal 2005, 2004 and 2003,
respectively. The estimated aggregate amortization expense will be approximately $355,000 for
each of the four succeeding fiscal years.
Deferred Financing Costs
Expenses incurred in connection with the Credit Facility and the previously issued guarantee
related to the Credit Facility had been deferred and were amortized using the straight-line method
which approximates the interest method over the life of the facility or the guarantee, as
applicable (see Note 5).
Deferred Revenue
In April 2003, the Company executed a Physician Group Participation Agreement with Humana (the
Humana PGP Agreement). Pursuant to the Humana PGP Agreement, the Company agreed to assume
certain management responsibilities on a non-risk basis for Humanas Medicare, commercial and
Medicaid members assigned to
selected primary care physicians in Miami-Dade and Broward Counties of Florida. Revenue from this
contract consists of a monthly management fee intended to cover the costs of providing these
services. Simultaneously with the execution of the Humana PGP Agreement, the Company restructured
the terms of a $3.9 million contract modification note with Humana. Pursuant to the restructuring,
the contract modification note was cancelled and the Humana PGP Agreement contained a provision for
liquidated damages in the amount of $4.0 million, which can be asserted by
F-10
Humana under certain
circumstances. The initial term of the Humana PGP Agreement expired in March 2005 but the term of
the Humana PGP Agreement continues by its terms until the agreement is terminated by either party
subject to prior notice.
Because there were contingent circumstances under which future payments of liquidated damages to
Humana could equal the amount of debt forgiven, the $3.9 million gain that otherwise would have
been recognized from the extinguishment of the debt in the fourth quarter of Fiscal 2003 was
deferred. Under the terms of the Humana PGP Agreement, if the Company remained in compliance with
terms of the agreement, Humana, at its option, may reduce the liquidated damages at specified dates
during the term of the Humana PGP Agreement. To the extent that Humana reduced the maximum amount
of liquidated damages, a portion of the deferred gain was recognized in an amount corresponding to
the amount by which the liquidated damages were reduced. In Fiscal 2005 and Fiscal 2004, Humana
notified the Company that the maximum amount of liquidated damages had been reduced from $3.0
million to $0 and from $3.9 million to $3.0 million, respectively. Accordingly, the Company
recognized $3.0 million and $0.9 million of the deferred gain on extinguishment of debt in Fiscal
2005 and 2004, respectively.
Accounting for Stock-Based Compensation
The Company follows Accounting Principles Board Opinion No. 25, (APB No. 25) Accounting for
Stock Issued to Employees and related Interpretations in accounting for its employee stock
options. Under APB No. 25, when the exercise price of the Companys employee stock options equals
or exceeds the market price of the underlying stock on the date of grant, no compensation expense
is recognized (see Note 9). Stock options issued to independent contractors or consultants are
accounted for in accordance with SFAS No. 123 (SFAS No. 123), Accounting for Stock-Based
Compensation.
Although the Company follows APB No. 25 for its employee stock options, SFAS No. 148, Accounting
for Stock Based CompensationTransition and Disclosure, requires the Company to disclose pro forma
results of operations as if the Companys stock options had been accounted for using the fair value
provisions of SFAS No. 123. The Companys pro forma information follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
|
|
2005 |
|
|
2004 |
|
|
2003 |
|
Net income as reported |
|
$ |
15,891,492 |
|
|
$ |
4,652,954 |
|
|
$ |
58,598 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based employee
compensation expense
included in reported net
income, net of related tax
effect |
|
|
254,000 |
|
|
|
|
|
|
|
123,000 |
|
Deduct: |
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based employee
compensation expense
determined under SFAS No.
123 for all awards |
|
|
(1,372,348 |
) |
|
|
(375,327 |
) |
|
|
(120,168 |
) |
|
|
|
|
|
|
|
|
|
|
Pro forma |
|
$ |
14,773,144 |
|
|
$ |
4,277,627 |
|
|
$ |
61,430 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
As reported |
|
$ |
.32 |
|
|
$ |
.11 |
|
|
$ |
|
|
Pro forma |
|
$ |
.29 |
|
|
$ |
.10 |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
As reported |
|
$ |
.31 |
|
|
$ |
.09 |
|
|
$ |
|
|
Pro forma |
|
$ |
.28 |
|
|
$ |
.09 |
|
|
$ |
|
|
Earnings per Share
Basic earnings per share is computed by dividing net income or loss by the weighted average common
shares outstanding for the period. Diluted earnings per share reflects the potential dilution that
could occur if securities or other contracts to issue common stock were exercised or converted into
common stock or resulted in the issuance of common stock that then shared in the earnings of the
entity (see Note 6).
F-11
Revenue Recognition
The Company provides services to patients on either a fixed monthly fee arrangement with HMOs or
under a fee for service arrangement. Total medical services net revenue from continuing operations
relating to Humana approximated 78%, 75% and 73% for Fiscal 2005, 2004 and 2003, respectively.
Total medical services net revenue from continuing operations related to Vista approximated 22%,
25% and 23% for Fiscal 2005, 2004 and 2003, respectively.
Under the Companys full risk contracts with Humana and Vista, the Company receives a fixed monthly
fee from the HMOs for each patient that chooses one of the Companys physicians as their primary
care physician. The fixed monthly fee is typically based on a percentage of the premium received
by the HMOs from various payor sources. Revenue under these agreements is generally recorded in the
period services are rendered at the rates then in effect as determined by the respective contract.
As part of the Medicare Advantage program, the Centers for Medicare Services (CMS) periodically
recomputes the premiums to be paid to the HMOs based on updated health status of participants and
updated demographic factors. The Company records any adjustments to this revenue at the time that
the information necessary to make the determination of the adjustment is received from the HMO or
CMS.
Under the Companys full risk agreements, the Company assumes responsibility for the cost of all
medical services provided to the patient, even those it does not provide directly in exchange for a
percentage of premium or other capitated fee. To the extent that patients require more frequent or
expensive care than was anticipated by the Company, revenue to the Company under a contract may be
insufficient to cover the costs of care provided. When it is probable that expected future health
care costs and maintenance costs under a contract or group of existing contracts will exceed
anticipated capitated revenue on those contracts, the Company recognizes losses on its prepaid
health care services with HMOs. No contracts were considered loss contracts at June 30, 2005
because the Company has the right to terminate unprofitable physicians and close unprofitable
centers under its managed care contracts.
Under the Companys limited risk and no-risk contracts with HMOs, the Company receives a capitation
fee or management fee based on the number of patients for which the Company provides services on a
monthly basis. The capitation fee or management fee is recorded as revenue in the period in which
services are provided as determined by the respective contract.
Medical Service Expense
The Company contracts with or employs various health care providers to provide medical services to
its patients. Primary care physicians are compensated on either a salary or capitation basis. For
patients enrolled under full risk managed care contracts, the cost of specialty services are paid
on either a fee for service, per diem or capitation basis.
The cost of health care services provided or contracted for under full risk managed care contracts
is accrued in the period in which services are provided. In addition, the Company provides for an
estimate of the related liability for medical claims incurred but not yet reported based on
historical claims experience and current factors such as inpatient utilization and benefit changes
provided under HMO plans. Estimates are adjusted as changes in these factors occur and such
adjustments are reported in the year of determination. To further corroborate our estimate of
medical claims, an independent actuarial calculation is performed on a quarterly basis.
Reinsurance (stop-loss insurance)
Reinsurance premiums are reported as a health care cost and are included in medical service expense
in the accompanying Consolidated Statements of Income. Reinsurance recoveries are reported as a
reduction of related health care costs.
Recent Accounting Pronouncements
In May 2005, the FASB issued SFAS No. 154, Accounting Changes and Error Corrections, which replaces
APB No. 20, Accounting Changes, and SFAS No. 3, Reporting Accounting Changes in Interim Financial
Statements, and changes the requirements for the accounting for and reporting of a change in
accounting principles for all voluntary changes in accounting principles and to changes required by
accounting pronouncements in the unusual instance that the pronouncements do not include specific
transition provisions. This statement requires retrospective application to prior periods
financial statements of changes in accounting principles, unless it is impracticable to determine
the period specific effects or cumulative effect of the change. When it is impracticable to
determine the period specific effects of an accounting change on one or more individual prior
periods presented, this statement requires that the
F-12
new accounting principle be applied to the
balances of assets and liabilities at the beginning of the earliest period for which retrospective
application is practicable and a corresponding adjustment is to be made to the opening balance of
retained earnings for that period. When it is impracticable to determine the cumulative effect of
applying a change in accounting principle to all prior periods, it requires that the new accounting
principle be applied as if it were adopted prospectively from the earliest date practicable. This
statement defines retrospective application as the application of a different accounting
principle to prior accounting periods as if that principle had always been used or as the
adjustment of previously issued financial statements to reflect a change in the reporting entity.
It also redefines restatement as the revising of previously issued financial statements to
reflect the correction of an error. This statement also requires that a change in depreciation,
amortization, or depletion method for long-lived, nonfinancial assets be accounted for as a change
in accounting estimate effected by a change in accounting principle. It is effective for fiscal
years beginning after December 15, 2005. The impact of adoption of this statement is not expected
to be significant to the Company.
On December 16, 2004, the Financial Accounting Standards Board (FASB) issued FASB Statement No. 123
(revised 2004), Share-Based Payment (Statement 123(R)), which is a revision of FASB Statement No.
123, Accounting for Stock-Based Compensation (Statement 123). Statement 123(R) supersedes APB
Opinion No. 25, Accounting for Stock Issued to Employees, and amends FASB Statement No. 95,
Statement of Cash Flows. Generally, the approach in Statement 123(R) is similar to the approach
described in Statement 123. However, Statement 123(R) requires all share-based payments to
employees, including grants of employee stock options, to be recognized in the income statement
based on their fair values. Pro forma disclosure is no longer an alternative. Statement 123(R)
must be adopted as of the beginning of the first annual reporting period that begins after June 15,
2005. Early adoption is permitted in periods in which financial statements have not yet been
issued. The Company will adopt Statement 123(R) for the first quarter of Fiscal 2006.
As currently permitted by Statement 123, the Company accounts for share-based payments to employees
using the intrinsic value method under Accounting for Stock Issued to Employees, Accounting
Principles Board Opinion No. 25 (APB No. 25), and, as such, generally recognizes no compensation
cost for employee stock options. Accordingly, the adoption of Statement 123(R)s fair value method
is expected to have a significant impact on our results of operations for periods after its
adoption by the Company, although it will have no impact on our overall financial position. The
precise impact of adoption of Statement 123(R) cannot be predicted at this time because it will
depend on levels of share-based payments granted in the future. However, had we adopted Statement
123(R) in prior periods, the impact of that standard would have approximated the impact of
Statement 123 as described in the disclosure of pro forma net income and earnings per share in the
Accounting for Stock-Based Compensation section above. Statement 123(R) can be adopted under two
methods, the modified prospective or the modified retrospective applications. Under the modified
prospective application, compensation cost for the portion of awards for which the requisite
service has not been rendered that are outstanding as of the effective date should be recognized as
the requisite service is rendered on or after the effective date. The compensation cost for that
portion of awards should be based on the grant-date fair value of those awards as calculated for
either recognition or pro forma disclosure under Statement 123. Changes to the grant-date fair
value of awards granted before the effective date of Statement 123(R) are precluded. The modified
retrospective application may be applied to all prior years that Statement 123 was effective or
only to prior interim periods in the year of initial adoption if the effective date of Statement
123(R) does not coincide with the beginning of the fiscal year. The cumulative effect of the
initial application of Statement 123(R), if any, is to be recognized as of the effective date.
Statement 123(R) also requires the benefits of tax deductions in excess of recognized compensation
cost to be reported as a financing cash flow, rather than as an operating cash flow as required
under current literature. This requirement will reduce net operating cash flows and increase net
financing cash flows in periods after adoption. While the Company cannot estimate what those
amounts will be in the future (because they depend on, among other things, when employees exercise
stock options), there was no impact on operating cash flows recognized in prior periods for such
excess tax deductions.
Other Comprehensive Income
The Company had no comprehensive income items other than net income for all years presented.
Reclassifications
Certain prior year amounts have been reclassified to conform with the current year presentation.
F-13
NOTE 3
DISCONTINUED OPERATIONS
In an effort to streamline operations and stem anticipated operating losses, effective January 1,
2003, the Company terminated the Medicare and Medicaid lines of business for all of the independent
physician affiliates associated with one HMO. The terminated IPAs, which consisted of 29 physicians
at the time of the termination and are shown as discontinued operations, contributed approximately
$4.5 million in revenue and generated operating income of approximately $351,000 in Fiscal 2003.
On December 16, 2003, the Company announced that it would dispose of its home health operations.
The disposition occurred in transactions with three entities that acquired substantially all of the
existing home health operations in separate transactions that concluded on February 7, 2004. In
two of the transactions, the employees and patients of the Companys Medicare certified home health
agencies in Broward and Miami-Dade Counties of Florida were transferred to the acquirer and no
assets or liabilities were transferred. In the third transaction, the Company sold the stock of
its private duty home health agency subsidiary for a cash purchase price of $9,000. The Company
retained all of the related accounts receivable, as well as all obligations for payables which
existed as of the date of the sale. In accordance with Statement of Financial Accounting Standard
No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the home health
operations are shown as discontinued operations. As a result of the decision to dispose of its
home health operations, the Company assessed the recoverability of the long-lived assets associated
with the home health operations and recorded a disposal charge of $0.5 million during Fiscal 2004,
which consisted of the following:
|
|
|
|
|
Goodwill |
|
$ |
320,882 |
|
|
Equipment, furniture and leasehold improvements |
|
|
111,640 |
|
|
Other |
|
|
24,868 |
|
|
|
|
|
|
|
|
$ |
457,390 |
|
|
|
|
|
The home health operations contributed $3.1 million and $4.2 million in revenue and generated
operating losses of $1.7 million and $1.8 million during the fiscal years ended June 30, 2004 and
2003, respectively, before any corporate overhead allocation or interest expense.
Approximately 10 employees were terminated as a result of these transactions. In accordance with
Statement of Financial Accounting Standard No. 146, (SFAS No. 146) Accounting for Costs
Associated with Exit or Disposal Activities, the Company recorded $0.2 million of costs for
severance payments and accrued for lease obligations in the third quarter of Fiscal 2004. The
remaining loss incurred during Fiscal 2004 related to the operations of the home health operations
prior to February 7, 2004 and the cost of winding up home health activities, including billing and
collection of outstanding accounts receivables. Approximately $56,000
and $208,000 of liabilities from discontinued operations are
included in accrued expenses and other current liabilities as of
June 30, 2005 and 2004, respectively.
NOTE 4 EQUIPMENT, FURNITURE AND LEASEHOLD IMPROVEMENTS
Equipment, furniture and leasehold improvements are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Useful |
|
|
|
June 30, |
|
|
Lives |
|
|
|
2005 |
|
|
2004 |
|
|
(in years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Furniture, fixtures and equipment |
|
$ |
2,437,852 |
|
|
$ |
2,138,529 |
|
|
|
3-5 |
|
Furniture and equipment under capital lease |
|
|
522,109 |
|
|
|
406,128 |
|
|
|
5 |
|
Leasehold improvements |
|
|
157,225 |
|
|
|
150,943 |
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,117,186 |
|
|
|
2,695,600 |
|
|
|
|
|
Less accumulated depreciation |
|
|
(2,446,521 |
) |
|
|
(2,203,546 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
670,665 |
|
|
$ |
492,054 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense for the years ended June 30, 2005, 2004 and 2003 was approximately $243,000,
$230,000 and $204,000, respectively.
The Company has entered into various noncancellable leases for certain furniture and equipment that
are classified as capital leases. The leases are payable over 3 to 5 years at incremental borrowing
rates ranging from 8% to 11% per
F-14
annum. Accumulated amortization for assets recorded under capital
lease agreements was approximately $413,000 and $332,000 at June 30, 2005 and 2004, respectively.
Amortization of assets recorded under capital lease agreements was approximately $81,000, $56,000 and $99,000 for the years ended June 30, 2005,
2004 and 2003, respectively, and is included in depreciation expense for all years presented.
Future minimum lease payments under all capital leases are as follows:
|
|
|
|
|
For the year ending June 30, |
|
|
|
|
2006 |
|
$ |
76,404 |
|
2007 |
|
|
37,602 |
|
2008 |
|
|
4,419 |
|
2009 |
|
|
|
|
2010 |
|
|
|
|
|
|
|
|
|
|
|
118,425 |
|
Less amount representing imputed interest |
|
|
(10,715 |
) |
|
|
|
|
Present value of obligations under capital lease |
|
|
107,710 |
|
Less current portion |
|
|
69,349 |
|
|
|
|
|
Long-term capital lease obligations |
|
$ |
38,361 |
|
|
|
|
|
The
current portion of obligations under capital leases is classified
within accrued expenses and other current liabilities in the
accompanying consolidated balance sheets.
NOTE 5
DEBT
On December 30, 2004, the Company received cash of $1,040,000 from Humana in exchange for an
unsecured, non-interest bearing promissory note for an equal amount. The promissory note is
payable in 12 monthly installments of $86,666, through December 1, 2005, but Continucare can prepay
the promissory note in full or in part at any time without penalty or premium. As of June 30,
2005, the Company had made principal payments amounting to $520,000, reducing the outstanding
balance on the promissory note to $520,000. Amounts due under the promissory note are subject to
acceleration upon the happening of customary events of default, including the failure to make
payments of principal.
The Company has in place a credit facility that provides for a revolving loan to the Company of
$3.0 million (the Credit Facility). Effective March 31, 2005, the Company obtained an extension
of the maturity date for the Credit Facility until March 31, 2006. All terms of the Credit Facility
remained substantially unchanged, except for the addition of a requirement that the Company
maintain a minimum cash and cash equivalent balance of $1.0 million and the elimination of the
requirement that Dr. Frost, a principal shareholder of the Company and member of the Board of
Directors, personally guarantee the Companys obligations under the Credit Facility. In connection
with a previous extension of the Credit Facilitys maturity date in March 2004, an entity
controlled by Dr. Frost received 300,000 shares of the Companys common stock in consideration for
Dr. Frosts renewal of his guarantee. The shares of common stock issued were valued at $870,000
based on the market price of the Companys common stock on March 26, 2004, the date on which Dr.
Frost renewed his guarantee. This amount was recorded as deferred financing costs and was
amortized through March 31, 2005, the date on which Dr. Frosts guarantee expired. At June 30,
2005, there was no outstanding principal balance on the Credit Facility. Interest under the Credit
Facility is payable monthly at 2.9% plus the 30-day Dealer Commercial Paper Rate, which was 3.27%
at June 30, 2005. All assets of the Company serve as collateral for the Credit Facility.
Related party notes consist of convertible promissory notes issued to Frost Nevada Investments
Trust, an entity controlled by Dr. Frost, and a group of six investors. In April 2004, Frost
Nevada Investments Trust converted a promissory note which had an outstanding principal balance and
unpaid accrued interest of approximately $0.9 million into approximately 820,000 shares of common
stock in accordance with the terms of that note. The remaining related party notes bear interest
at 7% and mature on October 31, 2005.
During Fiscal 2004, we recorded other income of $2.2 million relating to the settlement of an
alleged Medicare obligation. The alleged obligation related to rehabilitation clinics that were
previously operated by one of our former subsidiaries and were sold in 1999. The Centers for
Medicare and Medicaid Services (CMS) had alleged that Medicare overpayments were made relating to
services rendered by these clinics and other related clinics during a period in which the clinics
were operated by entities other than us. In an effort to resolve the matter with CMS and avoid
aggressive collection efforts that could have disrupted our business, in 2002 we began making
payments to resolve the alleged liability while retaining the right to dispute the alleged
overpayments. We requested that CMS reconsider the alleged liability and in October 2003 we were
notified that the liability had been reduced from the
F-15
originally asserted amount of $2.4 million to $0.2 million.
NOTE 6
INCOME/LOSS PER SHARE
A reconciliation of the denominator of the basic and diluted earnings per share computation is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
|
2005 |
|
2004 |
|
2003 |
|
|
|
Basic weighted average number of shares outstanding |
|
|
50,231,870 |
|
|
|
43,763,835 |
|
|
|
40,776,903 |
|
Dilutive effect of stock options |
|
|
1,689,274 |
|
|
|
1,144,918 |
|
|
|
|
|
Dilutive effect of convertible debt |
|
|
84,920 |
|
|
|
4,323,963 |
|
|
|
|
|
|
|
|
Diluted weighted average number of shares outstanding |
|
|
52,006,064 |
|
|
|
49,232,716 |
|
|
|
40,776,903 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Not included in calculation of dilutive earnings per
share as impact is antidilutive: |
|
|
|
|
|
|
|
|
|
|
|
|
Stock options outstanding |
|
|
255,000 |
|
|
|
300,000 |
|
|
|
2,716,000 |
|
Warrants |
|
|
760,000 |
|
|
|
760,000 |
|
|
|
760,000 |
|
NOTE 7 RELATED PARTY TRANSACTIONS
On March 31, 2003, Dr. Frost extended his personal guarantee of the Companys Credit Facility
through March 31, 2004. In consideration of Dr. Frosts personal guarantee, the Company issued
1,500,000 shares of restricted stock to an entity related to Dr. Frost and increased the annual
interest rate on a note payable to an entity related to Dr. Frost from 7% to 9%. The shares of
common stock issued, which were valued at $525,000 based on the closing price of the Companys
common stock on March 31, 2003 when the guarantee was granted, were recorded as a deferred
financing cost and amortized over the term of the guarantee.
On March 30, 2004, Dr. Frost extended his personal guarantee of the Companys Credit Facility
through March 31, 2005 (see Note 5). In consideration of Dr. Frosts personal guarantee, the
Company issued 300,000 shares of common stock to an entity controlled by Dr. Frost. The shares of
common stock issued, which were valued at $870,000 based on the closing price of the Companys
common stock on March 30, 2004, were recorded as a deferred financing cost and were amortized over
the term of the guarantee.
Effective March 31, 2005, the Company obtained an extension of the maturity date for the Credit
Facility until March 31, 2006 without Dr. Frosts guarantee.
NOTE 8 RESTRICTED STOCK, STOCK OPTION PLAN AND WARRANTS
On September 23, 2002, the Company issued a combined total of 800,000 shares of restricted common
stock to Board members as compensation for their services. The value of the restricted stock award
of $112,000 (based on the closing price of the Companys common stock on September 23, 2002) has
been recorded as director compensation in the first quarter of Fiscal 2003. Also on September 23,
2002, two of the Board members elected to receive their compensation in the form of fully vested
stock options, which represented a combined total of 400,000 stock options. The fully vested stock
options have an exercise price of $0.36 per share and are valid for a ten-year period.
On October 30, 2002, the Company issued 100,000 shares of restricted common stock to a newly
elected Board member. The value of the 100,000 shares of restricted stock awarded of $11,000
(based on the closing price of the Companys common stock on October 30, 2002) was recorded as
director compensation in the second quarter of Fiscal 2003.
In August 2004, the Companys shareholders approved an amendment to the Amended and Restated
Continucare Corporation 2000 Stock Option Plan (the 2000 Stock Option Plan) to increase the
authorized shares for issuance upon the exercise of stock options from 4,000,000 to 7,000,000 and
to cover employees, directors, independent contractors and consultants of the Company. Under the
terms of the 2000 Stock Option Plan, options are granted at the fair market value of the stock at
the date of grant, with vesting up to four years and with an expiration generally 10 years after
the date of the grant.
F-16
Pro forma information regarding net income and earnings per share is required by SFAS No. 123, and
has been determined as if the Company had accounted for its employee stock options under the fair
value method of that Statement. The fair value for these options was estimated at the date of
grant using a Black-Scholes option pricing model with the following weighted-average assumptions
for 2005, 2004 and 2003, respectively: risk-free interest rates of 4.12%, 4.25% and 3.33%; dividend
yields of 0%; volatility factors of the expected market price of the Companys common stock of
101.2%, 106.5% and 107.9%, and a weighted-average expected life of the options of 10 years.
The Black-Scholes option valuation model was developed for use in estimating the fair value of
traded options which have no vesting restrictions and are fully transferable. In addition, option
valuation models require the input of highly subjective assumptions including the expected stock
price volatility. Because the Companys employee stock options have characteristics significantly
different from those of traded options, and because changes in the subjective input assumptions can
materially affect the fair value estimate, in managements opinion, the existing models do not
necessarily provide a reliable single measure of the fair value of its employee stock options.
The following table summarizes information related to the Companys stock option activity for the
years ended June 30, 2005, 2004 and 2003:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
|
|
2005 |
|
|
2004 |
|
|
2003 |
|
|
|
Number |
|
|
Weighted Average |
|
|
Number |
|
|
Weighted Average |
|
|
Number |
|
|
Weighted Average |
|
|
|
of Shares |
|
|
Exercise Price |
|
|
of Shares |
|
|
Exercise Price |
|
|
of Shares |
|
|
Exercise Price |
|
Outstanding at beginning of the year |
|
|
3,295,000 |
|
|
$ |
1.32 |
|
|
|
2,716,000 |
|
|
$ |
1.15 |
|
|
|
2,316,000 |
|
|
$ |
1.29 |
|
Granted |
|
|
1,225,000 |
|
|
|
1.54 |
|
|
|
2,425,000 |
|
|
|
1.22 |
|
|
|
400,000 |
|
|
|
0.36 |
|
Exercised |
|
|
(156,666 |
) |
|
|
.59 |
|
|
|
(546,000 |
) |
|
|
0.64 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
(549,334 |
) |
|
|
2.74 |
|
|
|
(1,300,000 |
) |
|
|
1.17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of the year |
|
|
3,814,000 |
|
|
|
|
|
|
|
3,295,000 |
|
|
|
|
|
|
|
2,716,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at end of the year |
|
|
1,728,333 |
|
|
|
|
|
|
|
945,000 |
|
|
|
|
|
|
|
2,360,997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average fair value per
share of options granted during the
year |
|
$ |
1.61 |
|
|
|
|
|
|
$ |
1.20 |
|
|
|
|
|
|
$ |
0.12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table summarizes information about options outstanding at June 30, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
Options Exercisable |
Range of |
|
|
|
|
|
Weighted Average |
|
|
|
|
|
|
Exercise |
|
Outstanding at |
|
Remaining |
|
Weighted Average |
|
Number |
|
Weighted Average |
Prices |
|
June 30, 2005 |
|
Contractual Life |
|
Exercise Price |
|
Exercisable |
|
Exercise Price |
|
$1.35-$2.86 |
|
|
1,749,000 |
|
|
|
9.36 |
|
|
|
$1.91 |
|
|
|
463,333 |
|
|
|
$1.87 |
|
$.35-$.69 |
|
|
2,065,000 |
|
|
|
7.39 |
|
|
|
$ .63 |
|
|
|
1,265,000 |
|
|
|
$ .61 |
|
The Company has 760,000 warrants outstanding at June 30, 2005 which are exercisable through
December 31, 2007, with exercise prices ranging from $7.25 to $12.50 per share.
Shares of common stock have been reserved for future issuance at June 30, 2005 as follows:
|
|
|
|
|
Convertible related party note |
|
|
77,645 |
|
Warrants |
|
|
760,000 |
|
Stock options |
|
|
4,883,334 |
|
|
|
|
|
|
Total |
|
|
5,720,979 |
|
|
|
|
|
|
F-17
NOTE 9 INCOME TAXES
The Company accounts for income taxes under FASB Statement No. 109, Accounting for Income Taxes.
Deferred income tax assets and liabilities are determined based upon differences between the
financial reporting and tax bases of assets and liabilities and are measured using the enacted tax
rates and laws that will be in effect when the differences are expected to reverse.
The Company recorded an income tax benefit of $7,175,561 for the year ended June 30, 2005. No
provision or benefit for income taxes was recorded for the years ended June 30, 2004 and 2003 as
the Company had substantial tax assets, described more fully below, which had not been recognized. The income tax (benefit)
provision from continuing operations consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
|
|
2005 |
|
|
2004 |
|
|
2003 |
|
|
|
|
Current: |
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
$ |
131,363 |
|
|
$ |
|
|
|
$ |
|
|
State |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
131,363 |
|
|
|
|
|
|
|
|
|
Deferred: |
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
|
2,411,423 |
|
|
|
|
|
|
|
|
|
State |
|
|
435,273 |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
2,846,696 |
|
|
|
|
|
|
|
|
|
Change in valuation allowance |
|
|
(10,153,620 |
) |
|
|
|
|
|
|
|
|
|
|
|
Total income tax benefit |
|
$ |
(7,175,561 |
) |
|
$ |
|
|
|
$ |
|
|
|
|
|
Deferred income taxes reflect the net effect of temporary differences between the carrying amount
of assets and liabilities for financial reporting purposes and the amounts used for income tax
purposes. The tax effects of temporary differences that give rise to deferred tax assets and
deferred tax liabilities are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
2005 |
|
2004 |
|
2003 |
|
|
|
Deferred tax assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Bad debt and notes receivable reserve |
|
$ |
294,922 |
|
|
$ |
706,992 |
|
|
$ |
4,620,512 |
|
Alternative minimum tax credit |
|
|
131,363 |
|
|
|
|
|
|
|
|
|
Other |
|
|
160,296 |
|
|
|
192,440 |
|
|
|
379,628 |
|
Impairment charge |
|
|
1,746,800 |
|
|
|
1,975,228 |
|
|
|
3,036,963 |
|
Capital loss carryover |
|
|
|
|
|
|
|
|
|
|
200,261 |
|
Net operating loss carryforward |
|
|
6,340,985 |
|
|
|
7,925,846 |
|
|
|
4,590,657 |
|
|
|
|
Deferred tax assets |
|
|
8,674,366 |
|
|
|
10,800,506 |
|
|
|
12,828,021 |
|
Deferred tax liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciable/amortizable assets |
|
|
(1,367,442 |
) |
|
|
(646,886 |
) |
|
|
(965,047 |
) |
Valuation allowance |
|
|
|
|
|
|
(10,153,620 |
) |
|
|
(11,862,974 |
) |
|
|
|
Deferred tax liabilities |
|
|
(1,367,442 |
) |
|
|
(10,800,506 |
) |
|
|
(12,828,021 |
) |
|
|
|
Net deferred tax asset |
|
$ |
7,306,924 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
SFAS No. 109 requires a valuation allowance to reduce the deferred tax assets reported if, based on
the weight of the evidence, it is more likely than not that some portion or all of the deferred tax
assets will not be realized. After consideration of all the evidence, both positive and negative
(including, among others, the Companys projections of future taxable income and profitability in
recent fiscal years), management determined that a valuation allowance of $0, $10,153,620 and
$11,862,974 was necessary at June 30, 2005, 2004 and 2003, respectively, to reduce the deferred tax
assets to the amount that will more likely than not be realized. The change in the valuation
allowance for the current period was $10,153,620 for the year ended June 30, 2005. At June 30,
2005, the Company had available net operating loss carryforwards of approximately $16,851,000,
which expire in 2020 through 2025. Certain of the Companys net operating loss carryforwards are
subject to annual limitations.
F-18
A reconciliation of the statutory federal income tax rate with the Companys effective income tax
rate for the years ended June 30, 2005, 2004 and 2003 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
|
2005 |
|
2004 |
|
2003 |
|
|
|
Statutory federal rate |
|
|
34.0 |
% |
|
|
34.0 |
% |
|
|
34.0 |
% |
State income taxes, net of federal income tax benefit |
|
|
3.63 |
|
|
|
3.63 |
|
|
|
3.63 |
|
Goodwill and other non-deductible items |
|
|
(3.46 |
) |
|
|
2.85 |
|
|
|
356.26 |
|
Change in valuation allowance |
|
|
(116.49 |
) |
|
|
(40.48 |
) |
|
|
(404.03 |
) |
Other |
|
|
|
|
|
|
|
|
|
|
10.14 |
|
|
|
|
Effective tax rate |
|
|
(82.32 |
)% |
|
|
0 |
% |
|
|
0 |
% |
|
|
|
NOTE 10 SHARE REPURCHASE PROGRAM
In May 2005, the Companys Board of Directors increased the Companys previously announced program
to repurchase shares of its common stock to a total of 2,500,000 shares. Any such repurchases will
be made from time to time at the discretion of our management in the open market or in privately
negotiated transactions subject to market conditions and other factors. As of September 1, 2005,
the Company had repurchased 957,467 shares of its common stock for approximately $2,453,000.
NOTE 11 EMPLOYEE BENEFIT PLAN
As of January 1, 1997, the Company adopted a tax qualified employee savings and retirement plan
covering the Companys eligible employees. The Continucare Corporation 401(k) Profit Sharing Plan
and Trust (the 401(k) Plan) was amended and restated on July 1, 1998. The 401(k) Plan is intended
to qualify under Section 401 of the Internal Revenue Code (the Code) and contains a feature
described in Code Section 401(k) under which a participant may elect to have his or her
compensation reduced by up to 70% (subject to IRS limits) and have that amount contributed to the
401(k) Plan. On October 25, 2001, the Internal Revenue Service issued a favorable determination
letter for the 401(k) Plan.
Under the 401(k) Plan, new employees who are at least 18 years of age are eligible to participate
in the 401(k) Plan after 90 days of service. Eligible employees may elect to contribute to the
401(k) Plan up to a maximum amount of tax deferred contribution allowed by the Internal Revenue
Code. The Company may, at its discretion, make a matching contribution and a non-elective
contribution to the 401(k) Plan. There were no matching contributions for the years ended June 30,
2005, 2004 or 2003. Participants in the 401(k) Plan do not begin to vest in the employer
contribution until the end of two years of service, with full vesting achieved after five years of
service.
NOTE 12 COMMITMENTS AND CONTINGENCIES
Legal Proceedings
The Company is a party to the case of JOAN LINDAHL v. HUMANA MEDICAL PLAN, INC., COLUMBIA
HOSPITAL CORPORATION OF SOUTH BROWARD d/b/a WESTSIDE REGIONAL MEDICAL CENTER, INPHYNET CONTRACTING
SERVICES, INC., CONTINUCARE MEDICAL MANAGEMENT, INC., LUIS GUERRERO AND JARSLAW PARKOLAP. This
case was filed on January 24, 2002 in the Circuit Court of the 17th Judicial Circuit in and for
Broward County, Florida and served on the companies and individuals in February 2003. The
complaint alleges vicarious liability for medical malpractice. The Company intends to defend
itself against this case vigorously, but its outcome cannot be predicted. The Companys ultimate
liability, if any, with respect to the lawsuit is presently not determinable.
The Company is a party to the case of MAUREEN MCCANN, AS PERSONAL REPRESENTATIVE OF THE ESTATE
OF WALTER MCCANN v. AJAIB MANN, M.D. AND CONTINUCARE CORPORATION. This case was filed on April
5, 2005, in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County,
Florida. The complaint alleges vicarious liability for medical malpractice. The Company intends
to defend itself against this case vigorously, but its outcome cannot be predicted. The Companys
ultimate liability, if any, with respect to the lawsuit is presently not determinable.
In May 2005, the Company received a Notice of Intent to Initiate Litigation for Medical Negligence
from legal
F-19
counsel to a former patient. In July 2005, the Notice of Intent to Initiate Litigation
for Medical Negligence was withdrawn.
The Company is also involved in other legal proceedings incidental to its business that arise from
time to time out of the ordinary course of business including, but not limited to, claims related
to the alleged malpractice of employed and contracted medical professionals, workers compensation
claims and other employee-related matters, and minor disputes with equipment lessors and other
vendors. The Company has recorded an accrual for medical malpractice claims, which includes
amounts for insurance deductibles and projected exposure, based on managements estimate of the
ultimate outcome of such claims.
Leases
The Company leases office space and equipment under various non-cancelable operating leases. Rent
expense under such operating leases was approximately $1.8 million for each of the years ended June
30, 2005, 2004 and 2003, respectively. Future annual minimum payments under such leases as of June
30, 2005 are as follows:
|
|
|
|
|
For the fiscal year ending June 30, |
|
|
|
|
2006 |
|
$ |
1,722,924 |
|
2007 |
|
|
1,654,634 |
|
2008 |
|
|
1,566,966 |
|
2009 |
|
|
404,014 |
|
2010 |
|
|
190,860 |
|
|
|
|
|
Total |
|
$ |
5,539,398 |
|
|
|
|
|
NOTE 13 VALUATION AND QUALIFYING ACCOUNTS
Activity in the Companys Valuation and Qualifying Accounts consists of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30, |
|
|
|
2005 |
|
|
2004 |
|
|
2003 |
|
|
|
|
Allowance for doubtful accounts related to
other receivables and accounts receivable: |
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period |
|
$ |
826,964 |
|
|
$ |
4,823,000 |
|
|
$ |
4,807,000 |
|
Provision for doubtful accounts |
|
|
15,787 |
|
|
|
104,296 |
|
|
|
44,000 |
|
Write-offs of uncollectible accounts receivable |
|
|
|
|
|
|
(4,100,332 |
) |
|
|
(28,000 |
) |
|
|
|
Balance at end of period |
|
$ |
842,751 |
|
|
$ |
826,964 |
|
|
$ |
4,823,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for doubtful accounts related to notes receivable: |
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period |
|
$ |
|
|
|
$ |
6,367,000 |
|
|
$ |
6,367,000 |
|
Provision for doubtful accounts |
|
|
|
|
|
|
|
|
|
|
|
|
Write-offs of uncollectible notes receivable |
|
|
|
|
|
|
(6,367,000 |
) |
|
|
|
|
|
|
|
Balance at end of period |
|
$ |
|
|
|
$ |
|
|
|
$ |
6,367,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation allowance for deferred tax assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of period |
|
$ |
10,153,620 |
|
|
$ |
11,862,974 |
|
|
$ |
12,099,730 |
|
Additions |
|
|
|
|
|
|
|
|
|
|
|
|
Deductions |
|
|
(10,153,620 |
) |
|
|
(1,709,354 |
) |
|
|
(236,756 |
) |
|
|
|
Balance at end of period |
|
$ |
|
|
|
$ |
10,153,620 |
|
|
$ |
11,862,974 |
|
|
|
|
F-20
NOTE 14 QUARTERLY CONSOLIDATED FINANCIAL INFORMATION (UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended June 30, 2005 (a) |
|
|
|
First |
|
|
Second |
|
|
Third |
|
|
Fourth |
|
|
Full |
|
|
|
Quarter |
|
|
Quarter |
|
|
Quarter |
|
|
Quarter |
|
|
Year |
|
|
|
|
Total revenue from continuing
operations |
|
$ |
26,208,017 |
|
|
$ |
27,113,675 |
|
|
$ |
29,775,441 |
|
|
$ |
29,133,980 |
|
|
$ |
112,231,113 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,109,029 |
|
|
$ |
2,138,397 |
|
|
$ |
1,471,455 |
|
|
$ |
11,172,611 |
|
|
$ |
15,891,492 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income per common share |
|
$ |
.02 |
|
|
$ |
.04 |
|
|
$ |
.03 |
|
|
$ |
.22 |
|
|
$ |
.32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per common share |
|
$ |
.02 |
|
|
$ |
.04 |
|
|
$ |
.03 |
|
|
$ |
.21 |
|
|
$ |
.31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended June 30, 2004 (a) |
|
|
|
First |
|
|
Second |
|
|
Third |
|
|
Fourth |
|
|
Full |
|
|
|
Quarter |
|
|
Quarter |
|
|
Quarter |
|
|
Quarter |
|
|
Year |
|
|
|
|
Total revenue from
continuing
operations |
|
$ |
25,063,399 |
|
|
$ |
24,368,236 |
|
|
$ |
25,900,705 |
|
|
$ |
26,491,762 |
|
|
$ |
101,824,102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
2,501,350 |
|
|
$ |
(354,808 |
) |
|
$ |
1,511,235 |
|
|
$ |
995,177 |
|
|
$ |
4,652,954 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income
(loss) per common
share |
|
$ |
.06 |
|
|
$ |
(.01 |
) |
|
$ |
.04 |
|
|
$ |
.02 |
|
|
$ |
.11 |
|
|
Diluted net income
(loss) per common
share |
|
$ |
.05 |
|
|
$ |
(.01 |
) |
|
$ |
.03 |
|
|
$ |
.02 |
|
|
$ |
.09 |
|
(a) |
|
As discussed in Note 3, effective January 1, 2003, the Company terminated the Medicare and
Medicaid lines of business for all of the physician contracts associated with one of its IPAs.
During Fiscal 2004, the Company disposed of its home health operations. These transactions are
shown as discontinued operations. Therefore, the above quarterly information has been
reclassified to agree with the current presentation. These reclassifications had no effect on
the previously reported net income (loss) or net income (loss) per share for any quarter
presented. |
F-21
EXHIBIT INDEX
|
|
|
|
|
Description |
|
Exhibit Number |
Consent of Independent Registered Public Accounting Firm
|
|
|
23.1 |
|
|
|
|
|
|
Section 302 Certification of Chief Executive Officer
|
|
|
31.1 |
|
|
|
|
|
|
Section 302
Certification of Chief Financial Officer
|
|
|
31.2 |
|
|
|
|
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
|
|
|
32.1 |
|
|
|
|
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
|
|
|
32.2 |
|